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   ABSTRACT  
 





Understanding how phenotype relates to genotype, in terms of the myriad molecular 
processes that govern the behavior of cells and organisms, has been one of the central 
goals of biology for a long time. Transcription factors (TFs) play a mediating role 
connecting genotype with gene expression, which provides high-dimensional information 
about end phenotype. In particular, gene expression levels depend on their cis-regulatory 
sequence bound by TFs and condition-specific regulatory activity of TFs determined by 
its modulators through interaction with cofactors or signaling molecules. This thesis 
consists of two parts that related to the overall goal of dissecting upstream modulators of 
transcription factor activity. The first study is to dissect genetic determinants of 
transcription factor activity in a segregating population. We exploit prior knowledge 
about the in vitro DNA-binding specificity of a TF in order to map the loci (‘aQTLs’) 
whose inheritance modulates its protein-level regulatory activity. The second study is to 
identify regulatory mechanisms underlying tumorigenesis in mice by using genotyping 
and gene expression data across a set of 97 splenic tumors induced by retroviral 
insertional mutagenesis. We identify several instances of sequence-specific TFs whose 
activities are specifically affected by insertions mutations. Our results underscore the 
value of explicitly modeling TF activity and a strategy for finding upstream modulators 
of TF activity.   
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Chapter 1                                                 
Introduction  
Genetic variation perturbs phenotype. Understanding how phenotype relates to genotype, 
in terms of the myriad molecular processes that govern the behavior of cells and 
organisms, is one of the central goals of biology for a long time. The genetic information 
in DNA sequence, along with epigenetic information, controls the gene expression and 
phenotypes. On the road from genotype to phenotype, many layers of regulations, 
including chromatin state [1], transcriptional rate [2], splicing [3], mRNA localization 
[4], mRNA stability [5], translational rate [6], and protein stability [7], are programmed 
to act at the right time. Therefore, it is required to obtain additional functional 
information to elucidate precise regulatory networks underlying phenotypes. 
 Recent technology development greatly facilitated understanding the molecular 
process in a cell. Genome-scale technologies made possible by the emergence of 
microarray technology since the early 1990s [8] have allowed unbiased, genome-wide 
views of genetic networks in different ways. cDNA microarrays have led to analyze gene 
expression patterns globally in various conditions and genetic backgrounds for genome-
wide modeling of transcriptional networks [9, 10]. Additionally, microarray techniques 
were used to determine the large-scale genotype [11, 12]. These days, as many as 
500,000 SNPs can be profiled at the same time for thousands of individuals. High-
throughput SNP genotyping makes it possible to perform genome-wide association 
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(GWA) studies for identifying disease loci. Furthermore, microarrays also have been 
adopted to determine the genomic binding sites of transcription factors in genome scale 
[13]. A more recent high-throughput sequencing technology has been used to sequence 
cDNA in order to get information about RNA contents at a high resolution (i.e. RNA-seq) 
[14], and combined with chromatin immunoprecipitation (ChIP) to identify the binding 
sites of DNA-associated proteins (i.e. ChIP-seq) [15]. 
 TFs play central roles in the regulation of gene expression that further determines 
phenotypes (Figure 1.1). They bind specific DNA sequences and recruit other proteins 
such as chromatin remodeling factors, RNA polymerase, and histone-modifying factors 
to the genome sequence. Furthermore, they regulate gene expression in a condition-
specific manner through interaction with cofactors or signaling molecules.  
 
Figure 1.1: TFs as a crucial layer of regulation. The genomic information in DNA 
regulates gene expression level, and further end phenotypes through condition-specific 
regulatory activity of transcription factors 
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 This thesis consists of two parts that both relate to the overall goal of dissecting 
genetic determinants of transcription factor activity. In the first part, we aim to identify 
genetic modulators of TFs activity. In particular, we propose a method that exploits prior 
knowledge about the in vitro DNA-binding specificity of a TF in order to map the loci 
(‘aQTLs') whose inheritance modulates its protein-level regulatory activity. Genome-
wide regression of differential mRNA expression on predicted promoter affinity is used 
to estimate segregant-specific TF activity, which is subsequently mapped as a 
quantitative phenotype. Furthermore, we have extended this approach to other biological 
contexts, including post-transcriptional regulatory networks and the promiscuous binding 
of TFs to high-occupancy target (HOT) regions. 
 In the second part, we aim to identify regulatory mechanisms underlying 
tumorigenesis in mice using a set of 97 splenic tumors induced by retroviral insertional 
mutagenesis. We present locus expression signature analysis (LESA), a novel approach 
that defines and exploits the gene expression signature associated with each insertion. To 
identify regulatory mechanisms of tumorigenesis, we hypothesized that gene expression 
is affected by the insertional mutations through one of two mechanisms: (i) regulation by 
sequence-specific transcription factors (TFs) or (ii) changes in chromosomal domain 
organization leading to changes in gene expression. We also investigated the relationship 
between drug response and my locus-specific expression signatures. 
 This thesis is organized into six chapters. Chapter 2 provides background to cover 
main concepts required to understand later chapters; background on genetical genomics 
approach, retroviral insertional mutagenesis screens, and key aspects of transcription 
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factors as a crucial layer of regulation. Chapter 3 describes our aQTL approach, a method 
that exploits prior knowledge about the in vitro DNA-binding specificity of a TF in order 
to map the loci (‘aQTLs') whose inheritance modulates its protein-level regulatory 
activity. Chapter 4 describes the extension of the aQTL approach to other biological 
contexts, including the promiscuous binding of TFs to high-occupancy target (HOT) 
regions and post-transcriptional regulatory networks. Chapter 5 describes locus 
expression signature analysis (LESA), a novel approach that defines and exploits the 
gene expression signature associated with each insertion using gene expression levels of 
tumors induced by retroviral insertional mutagenesis screens in mouse. Chapter 6 
summarizes our findings and provides some possible future directions for this work.   
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Chapter 2                                                 
Background and Literature Review  
This chapter is intended to cover the main concepts required to understand later chapters, 
and to examine the relevant literature in the field. First, we give an introduction to 
‘genetical genomics’ approaches [16] that use parallel high-throughput gene expression 
and genotype data to identify expression quantitative trait loci (eQTLs). We continue 
with background on retroviral insertional mutagenesis screens. Finally, we review the key 
aspects of transcription factors, which are crucial players in the regulation of gene 
expression.    
2.1 Natural variations to perturbs expression levels 
How phenotype relates to genotype in terms of the molecular processes that govern the 
behavior of the cell is one of the central questions in biology. After the rediscovery of 
Mendel’s paper in 1900, the genetic variation in populations became a subject of 
scientific inquiry for a long time. Much effort has been devoted to identifying causative 
DNA variants and elucidating the mechanisms underlying diverse phenotype. Gene 
expression levels represent an intermediate molecular phenotype of great utility. They 
provide high-dimensional information about the cellular state. Gene expression also 
provides a universal sub-phenotype for complex and heterogeneous organismal 
phenotypes. Furthermore, the emergence of microarray technology in the early 1990s has 
greatly facilitated quantitative measurements of mRNA abundance, and made it possible 
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to analyze gene expression patterns globally in order to understand the molecular 
pathways underlying the organismal phenotypes.   
 Dissecting natural variations in gene expression improves our understanding of 
the molecular processes underlying phenotypes. In this section, we give an overview of 
the recent strategies used to find the natural variations that perturb gene expression, 
which are called expression quantitative trait loci (eQTLs), and describe the features of 
the two types of regulatory sequence variation underlying differences in gene expression 
as well as methods for identifying master regulators responsible for the large number of 
genes.  
2.1.1 Parallel use of high-throughput genotype and gene expression data 
Building on a long history in small scale studies to understand genetic variation in gene 
expression [17, 18], Jansen and Nap proposed genetic mapping of genome-wide gene 
expression, which is called ‘genetical genomics’ [16] (Figure 2.1).  The use of parallel 
high-throughput genotyping and expression profiling on segregating populations has 
enabled researchers to ask quantitative questions regarding the genetics of genome-wide 
expression in a variety of organisms [16, 19-22]. Genetical genomics has provided 
substantial additional insight into the functional landscape of gene regulation, improved 
our understanding of transcriptional regulation and regulatory variation, and provided a 
new approach for connecting DNA sequence variation with phenotype variation.  
 For any genetic study it is required to demonstrate that the trait in question is 
influenced by inherited factors. Although the exact heritability estimates depends on 
factors such as sample size, tissue type, statistical mode, amount of genetic diversity and 
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environmental variability [23], genetical genomics studies have revealed that hundreds to 
thousands of steady-state mRNA abundance for individual genes are highly heritable. 
Therefore, mRNA abundance can be treated as a quantitative trait in classical genetics 
methods (Figure 2.1), and the expression quantitative trait loci (eQTLs), whose allelic 
variation influences the expression level of individual genes, have successfully been 
mapped in a number of model organisms from yeast to mouse [19-22] using linkage 
analysis or association mapping. 
 
Figure 2.1: Genetical genomics approach. 40 segregants obtained by crossing the parental 
strains are genotyped for a set of markers that cover the genome. Two different parental 
alleles and genome blocks are indicated by green and blue, respectively. The expression 
profiling of each segregant also is obtained. The expression level of each gene is treated 
as a quantitative trait and analyzed across the 40 segregants with to map expression 
quantitative trait loci (eQTLs). This method detects the significant genes whose 
expression levels are explained by the genetic variation between the two parental strains 
through either upregulation (Up) or downregulation (Down) in gene expression (N.S., not 
significant change). Several gene transcripts were found that map to two or more loci. In 
diagram, horizontal line represents locations of eQTL and vertical line represents location 
of genes affected by eQTL. eQTL can be cis-acting (dotted line at an angle) or trans-
acting (dotted vertical lines). Figure taken from [24]  
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 mRNA abundance differs from other phenotypes in many ways, in regards of 
understanding of its genetics. First, the genome-wide gene expression profiles provide a 
large and unbiased set of traits that can be assayed simultaneously. The study of these 
traits can provide a detailed landscape of transcriptional regulation, but statistical 
methods for analysis of eQTL mapping are required to adjust for multiple tests due to 
large number of trait-marker combinations. Efforts have generally involved controlling 
false discovery rate (FDR), and approaches to control FDR have relied on calculations of 
q-values as described in Storey and Tibshirani [25] or on permutations [26]. Each 
transcript whose abundance treated as a trait has a corresponding encoding gene with a 
known position in the genome. This special feature provides mechanisms underlying 
DNA variations on gene expression, and will be discussed in the next section.  
2.1.2 Mapping eQTLs: local versus distal QTLs 
eQTL studies have extended our understanding of the contribution of cis- versus trans-
acting variation to the expression of any given gene. According to the relative genomic 
locations of transcript and its QTL, an expression QTL can be explicitly classified as 
'local' (near the genomic location of the gene encoding the transcript) or 'distal' 
(elsewhere in the genome) [27]. The mode of effect of regulatory variants is further 
investigated to understand the underlying molecular nature of eQTLs (Figure 2.1).   
 Local eQTL linkages frequently act as cis-acting polymorphisms [28]. The 
polymorphisms in the cis-regulatory region alter transcription factor binding sites, and 
consequently may alter transcription levels. They also affect mRNA abundance in a post-
transcriptional way, such as through changes in mRNA stability or processing. Many 
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eQTL studies have reported that the strongest eQTLs are most frequently classified as 
local eQTLs [29-31], suggesting that the transcription factor binding involved in RNA 
polymerase II recruitment or post-transcriptional regulations are key components of 
transcriptional regulation. On the other hand, trans-acting local variation is also likely to 
be partly responsible for the local eQTL linkages. The polymorphisms in the coding 
region might change the mRNA abundance by triggering feedback loops or an auto-
regulatory mechanism [27]. One study experimentally confirmed such a hypothesis that 
the local regulatory variation acts in trans through a feedback loop [28].  
 Distal regulatory variation typically acts in trans. The most obvious hypothesis is 
that trans-acting polymorphisms should be enriched near transcription factor genes, or 
these trans-eQTL genes can mediate the effect of a transcription factor instead of directly 
encoding a transcription factor. Even though distal regulation can occur with many 
degrees of indirectness, consistent with the observation that distal acting elements exert a 
weaker influence than local QTLs [29-31], many researches have explored causal 
relationships underlying trans-eQTLs. It is because trans-acting polymorphisms at distal 
loci can influence the expression of large numbers of genes in countless ways by 
changing the state and/or connectivity of the gene regulatory network of the cell [32]. It is 
therefore expected that such polymorphisms account for much of the genetic variance of 
gene expression.  
2.1.3 Methods for finding master regulators   
In addition to sequence variations that affect single transcript phenotypes in cis or in 
trans, previous eQTL studies have shown that genomic regions containing transcription 
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regulators influence expression levels of hundreds of genes, and seem to be responsible 
for most differences in gene expression [19, 21, 32, 33]. This existence of ‘master 
regulators’ makes it possible to enrich our understanding of regulatory networks, and 
many researchers have tried to identify such regulators.    
 Perhaps the simplest method for finding master regulators is to identify eQTL 
“hotspots” that influence the expression of a disproportionate number of genes [19]. A 
number of such hotspots have been identified in yeast and other organisms [27]. The 
genes that link to a particular hotspot are often enriched for specific biological functions, 
and tend to be controlled through the same regulatory sub-network [19, 34]. A different 
approach has been to map trans-acting loci for sets of co-expressed genes identified using 
hierarchical clustering [32] or more sophisticated module inference algorithms [35]. 
However, methods based on co-expression are most useful when a relatively small 
number of cell state parameters are perturbed and the expression of large subsets of genes 
changes in a coherent way. One expects them to be less naturally suitable for analyzing 
natural gene expression variation, where the segregation of alleles in a genetic cross 
causes a very large number of cell state parameters to be independently perturbed. 
Indeed, with some exceptions, the number of genes in genetic co-expression modules is 
very small [32, 35]. Principal Component Analysis (PCA) [36] of the matrix of genes by 
segregants, and extensions of PCA that incorporate qualitative information about 
regulatory network topology [37-39], have also been applied to map trans-acting loci. 
While these methods all improve upon single-gene based approaches, the lion’s share of 
the heritable variation in gene expression remains to be accounted for.   
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2.2 Mutagenesis using retrovirus to generate tumors  
Cancer arises as a result of the accumulation of genetic and epigenetic changes that 
deregulate a specific aspect of normal cell function. High-throughput technologies for 
mapping genetic and chromosomal aberrations have revealed complex changes in 
genomes of individual tumors [40-43]. However, It is difficult to determine whether such 
mutations are causal “driver” mutation or an incidental “passenger” mutation. Genetic 
screens can greatly facilitate to identify causal genes involved in tumorigenesis in model 
organisms such as the mouse. Retroviral insertional mutagenesis screens in mice are 
efficient tools for identification of oncogenic mutations in an in vivo setting [44, 45]. 
Recent advances in sequencing technology and availability of the mouse genome 
sequence have had a large effect on the potential of insertional mutagenesis screens.  In 
this chapter, we discuss the detailed features of retroviral insertional mutagenesis screens, 
including the mechanisms of mutation and the previous oncogenes discovered from this 
screening method, and identification of common insertions sites.  
2.2.1 Oncogenic retroviruses as a tool for genetic screening 
Oncogenic retroviruses can cause cancer in various species. They generally can be 
divided into two classes according to their mechanisms: acute and slow transforming 
viruses. These two classes have two distinct molecular mechanisms of retroviral 
oncogenesis. The Abelson Murine leukaemia Virus (AML) [46] and avian myoblastosis 
virus (AMV) [47] are acute transforming retroviruses and express viral oncogene v-Abl 
and v-Myb, respectively. This type of retrovirus usually generates tumors within 2-3 
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weeks after infection through expression of virally encoded oncogenic versions of normal 
cellular genes in host cells.  
 Slow transforming retroviruses do not carry viral oncogenes, but can induce 
tumors through mutation of the cellular genes caused by integration of their proviruses 
into the host genome. This type of retrovirus usually induces tumors within 3-12 months. 
Elements in the proviral genome that regulate the viral transcript act in cis on cellular 
gene transcripts. Such oncogenic mutations by these elements may either cause alteration 
of a gene product or influence the expression levels of one or more genes surrounding the 
insertion depending on where the provirus integrate into. Genetic screens using slow 
transforming retrovirus have efficiently been used to discovery cancer genes in various 
model organisms like cats (FeLV), birds (ALV and REV) and mice (murine leukaemia 
virus (MuLV)).  
2.2.2 Proviral insertions drive tumorigenesis  
To initiate murine leukemia virus (MuLV)-mediated insertional mutagenesis, newborn 
mice are infected with MuLV by injection with virus-producing cells (Figure 2.2). The 
virus will infect host cells, and the insertion of proviruses in the genome of the host cell 
can mutate cellular genes in multiple ways. The affected cell will expand in a clonal 
outgrowth given that the mutations caused by provirus insertions have a selective 
advantage. Cells acquiring multiple mutations induced by repeated infections can 
generate the development of a tumor. The proviral insertion site can be easily identified 
by amplification of the genome sequences flanking the retroviral insertion, and mapping 
the resulting sequences on to the genome. 
  
13 
 The ability to induce multiple mutations in the same cell makes slow retroviruses 
very suitable for genetic screens for oncogenic mutations [44, 45]. It is not 
straightforward to acquire multiple mutations from retroviral infection. This is because 
after incorporation of the provirus into the genome, cells will start producing viral 
envelope proteins and cell surface receptors become occupied with these proteins, thus 
inhibiting reinfection of the cell. Mutant viruses encoding non-functional envelope 
proteins created by recombination of the viral sequences with endogenous viral 
sequences can utilize different receptors, and re-infect an infected cell [44, 45].  
 The proviral insertions in the genome of the host cell can mutate cellular genes in 
different ways [44]. It results in enhanced transcripts levels, viral-host fusion transcripts 
or truncation of gene transcripts. In particular, mutation of cellular genes by proviral 
insertions is mediated by proviral elements that drive and regulate retroviral transcription. 
These elements are present in the Long Terminal Repeats (LTRs) at the end of the 
provirus and contain an enhancer, promoter region, the start and termination sites of 
transcription. The promoter sequence in the LTR such as a TATA box and GC-rich 
sequences can recruit the basal transcription machinery [48]. On the other hand, the 
enhancer region contains binding sites for various transcription factors [49-51], which is 




Figure 2.2: Retroviral insertional mutagenesis screens. The infection of mice by MuLV 
induces mutation in multiple ways by integration of the retrovirus into the host genome. 
According to the location of insertions, truncating, inactivation, overexpression or 
misexpression of cellular genes can be induced. Cells can be re-infected by the virus and 
accumulate multiple mutations that induce tumors. Figure taken from [45]. 
2.2.3 Identification of oncogenes and tumor suppressor genes  
Many of the screens published to date identify hundreds of insertions [52-60]. Recent 
advances in sequencing technology and availability of the mouse genome sequence had a 
large effect on the potential of insertional mutagenesis screens. One recent screen yielded 
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an average of 20 insertions per tumor, in total, 10,806 independent insertions for 510 
tumors [61]. To date, more than 10,000 genomic regions where retroviral insertions are 
found in close proximity in multiple tumors (referred as Common Insertion Sites or CISs) 
have been identified in Retroviral Tagged Cancer Gene Database (RTCGD) 
(http://variation.osu.edu/rtcgd) [62].  
 Many regions that are targeted in multiple independent tumors show a significant 
overlap with oncogenes and tumor suppressor genes, validating the use of this screening 
strategy. For example, insertion by retrovirus near the c-Myc proto-oncogene is 
frequently found to induce tumors like erythroleukaemias and T-cell lymphomas [63]. 
The previous studies also detected that the proviral insertions in the 3’UTR region of the 
Pim1 and Nmyc gene induce tumors by removal of regulatory or destabilizing motifs in 
mRNAs [64, 65]. Furthermore, tumor suppressor genes such as neurofibromatosis 1 
(Nf1) have been identified by retroviral tagging [59]. The large-scale mutagenesis also 
detected frequent insertion near tumor suppressor genes such as Ikaros, Zfpn1a3, Nf1l, 
Ovca2 and Wwox [61].  
2.2.4 Method for finding common insertion sites  
A common insertion site (CIS) is defined as a region in the genome that has been hit by 
viral insertions in multiple independent tumors significantly more frequently than 
expected by chance. Not all insertions are causal to tumor development. Non-oncogenic 
insertions can be detected in the tumors when this insertion co-occurs with oncogenic 
insertions early in the tumor development phase. However, it is unlikely to detect this 
non-oncogenic insertion in the other independent tumor. The insertions found at the same 
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locus for multiple independent tumors are likely to be a result of selective expansion of 
tumor cells. Therefore, finding CISs greatly reduce the probability of detecting non-
oncogenic insertion.  
 To identify CISs, researchers have calculated random distribution of insertions 
with fixed windows in the genome assuming a Poisson distribution [56] or using Monte 
Carlo simulation [59]. However, as the number of insertions in a study increases, these 
fixed window size can increase the probability to detect false CISs: the small window 
size can reduce the number of false detections, but biologically this is undesirable 
because some retroviruses can affect gene expression over distances much larger than 30 
kb [66]. On the other hand, the large window size can increase the detection of false 
CISs. Therefore, more sophisticated statistical methods are required.  
  One study proposed a statistical framework based on Gaussian kernel 
convolution (GKC), which estimates a smoothed density distribution of inserts over the 
entire genome [67]. Depending on choice of kernel size and p-value, the total number of 
statistically significant CISs varies. The smaller window size separates CISs that 
influence the same gene, on the other hand, the increasing window size may result in 
merging of independent CISs. This framework can consider CISs and evaluate their 
significance level with varied window width, and connect to biological relevance in the 
behavior of CISs. They also provide the background insertion distribution required for 
analyzing preferential insertions near transcription start sites.  
 It is not straightforward to determine which genetic lesions near a CIS are playing 
a causal role in oncogenesis. The effect of insertions on the nearby targets is dependent 
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on the relative position and orientation of the target transcript as well as the orientation of 
the viral integration. To exploit this information, the previous study has employed a rule-
based mapping (RBM) procedure [68]. RBM distinguishes insertions by their occurrence 
within a transcript, or outside a transcript. Based on the orientation and locus of an 
insertion, RBM assigns one or more target transcripts to an insertion. RBM is based on 
the assumption that the influence of insertions on gene expression of nearby genes is 
dependent on the distance of the insertion to the gene. The unique list of transcripts that 
follows from the procedure is used to generate binary profiles that, for each tumor, 
indicate if a transcript is a putative target. It was observed that the proximal transcripts 
frequently results the same binary profile. These were therefore combined into a single 
profile [68].  
2.3 TFs as a crucial layer of gene regulation   
The genome-wide pattern of steady-state mRNA levels constitute an intermediate 
molecular phenotype, and their condition-specific regulation is mainly mediated by 
transcription factors (TFs). The transcription factors act by sequence-specific binding to 
regulatory DNA elements in the vicinity of their target genes. Additionally, the condition-
specific regulation by TFs is explained by their regulatory activity and involvement of 
other proteins such as cofactors or signaling molecules. In this section, we discuss the key 
aspects of transcription factors as a crucial layer of gene expression regulation.  
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2.3.1 Predicting the sequence specificity of transcription factors   
Transcription factors contain a DNA-binding domain (DBD) that determines sequence-
specific binding to regulatory DNA elements. Microarray techniques used to facilitate the 
measurement of the sequence specific binding of TFs along the genome. Chromatin 
immunoprecipitation followed by microarray hybridization (ChIP-chip) and DNA 
adenine methyltransferase identification (DamID) have allowed genomic mapping of 
transcription factors in various conditions [13, 69, 70]. Nucleosome occupancy and 
covalent modifications to histones have also been assayed [70-72]. Recently, high-
throughput sequencing, ChIP-seq, can profile high-resolution mapping of protein-DNA 
interactions [15].  DIP-chip and protein-binding microarrays (PBMs) have been used to 
determine the in vitro sequence specificity of DNA-binding proteins [73, 74].  
 It is important to model the interaction between protein and DNA sequence to 
have accurate quantitative information about the DNA binding specificity of TFs. Berg 
and Von Hippel [75] developed a theoretical framework to parameterize protein-DNA 
sequence specificity using position weight matrix (PWM), assuming additivity of the 
binding energy for each base pair. However, the position-specific scoring matrix (PSSM), 
whose entries can be related to binding free energies and defined from PWMs, does not 
represent the accurate quantitative information about sequence specificity from a 
biophysical view because binding energies are inferred up to an unknown scaling factor.  
 High-throughput technology has allowed inference of more accurate TF binding 
specificity using biophysical models [76-79]. In particular, Foat et al. [78] represents 
DNA binding specificity of transcription factors (TFs) in the form of position-specific 
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affinity matrices, whose affinities at each position are directly related to the free energy 
of binding. Therefore, these matrices can be used to predict the accurate quantitative 
affinity with which each TF binds to the promoter region of each gene [80]. 
2.3.2 Construction of regulatory network connectivity  
To understand the comprehensive regulation of gene expression by transcription factors, 
the regulatory connectivity, that is, which genes are the targets of TFs, should be solved. 
Many studies have predicted regulatory connectivity based on a genome-wide expression 
levels. The regulatory connectivity has been first analyzed by clustering of expression 
profiles across multiple conditions [81]. The resulting disjoint sets of genes are 
considered co-regulated and their promoter sequences are investigated to find binding of 
regulators [82-84].   
 Another class of approaches explicitly parameterizes the condition-specific 
activity of transcription factors using prior information about the physical interaction 
between TFs and DNA sequence. To construct regulatory network connectivity, some 
studies have relied the mRNA expression levels of the gene encoding the TF as a 
surrogate for the condition-specific regulatory activity of the TF [85]. However, the 
regulatory activity of a TF is usually not well predicted by its mRNA expression level 
[86]. Most TFs are modulated at the post-translational level through non-covalent 
modification by signaling proteins, changes in the subcellular localization of the TF 
protein, and the availability of co-factors. Other methods estimated post-translational 
activity of each TF using cis-regulatory sequence and the expression level of target genes. 
The condition specific TF activity is determined as expression changes in terms of counts 
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of regulatory motifs in its promoter regions using multivariate linear regression [87] or 
elaborated feature selection method [88]. With availability of large-scale data, a more 
recent approach that is motivated by a biophysical description of gene expression 
regulation used prior information about sequence specificity of transcription factors to 




Chapter 3                                                    
Identifying the genetic determinants of 
transcription factor activity: aQTL  
This chapter has been adapted from an article by Eunjee Lee and Harmen J. Bussemaker 
that was published in the journal Molecular Systems Biology [90].  
3.1 Abstract  
Analysis of parallel genotyping and expression profiling data has shown that mRNA 
expression levels are highly heritable. Currently, only a tiny fraction of this genetic 
variance can be mechanistically accounted for. The influence of trans-acting 
polymorphisms on gene expression traits is often mediated by transcription factors (TFs). 
We present a method that exploits prior knowledge about the in vitro DNA-binding 
specificity of a TF in order to map the loci (‘aQTLs') whose inheritance modulates its 
protein-level regulatory activity. Genome-wide regression of differential mRNA 
expression on predicted promoter affinity is used to estimate segregant-specific TF 
activity, which is subsequently mapped as a quantitative phenotype. In budding yeast, our 
method identifies six times as many locus-TF associations and more than twice as 
many trans-acting loci as all existing methods combined. Application to mouse data from 
an F2 intercross identified an aQTL on chromosome VII modulating the activity of 
Zscan4 in liver cells. Our method has greatly improved statistical power over existing 
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methods, is mechanism based, strictly causal, computationally efficient, and generally 
applicable. 
3.2 Introduction  
We here present a transcription-factor-centric and sequence-based method for the 
dissection of genetic expression variation. A key feature of our approach is the use of 
quantitative prior information about the DNA-binding specificity of transcription factors 
(TFs) in the form of position-specific affinity matrices [80]. These matrices are used to 
predict the affinity with which each TF binds to the promoter region of each gene. We 
use a linear regression model motivated by a biophysical description of gene expression 
regulation [80, 87] to explain the genome-wide transcriptional response to the genetic 
perturbations in each segregant in terms of changes in ‘hidden' TF activity. Treating the 
latter as a quantitative trait allows us to map the activity quantitative trait loci (‘aQTLs') 
whose allelic status modulates the regulatory activity of specific TFs. 
 As we will demonstrate below, our method has a greatly improved statistical 
power to detect regulatory mechanisms underlying the heritability of genome-wide 
mRNA expression. Specifically, it identified six times as many locus-TF associations 
from a genetic cross between two haploid yeast strains as all existing methods combined. 
This includes novel trans-acting polymorphisms in the TF-encoding gene STB5,RFX1, 
and HAP4. We also identified 20 previously unknown trans-acting loci. Furthermore, for 
many of the 13 known eQTL hotspots in yeast, our method implicated several TFs that 
were not previously known to mediate the effect of inheritance of these loci on gene 
expression levels. We validated our ability to predict locus-TF associations in yeast using 
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gene expression profiles for allele replacement strains. Finally, application to mouse data 
identified an aQTL modulating the activity of a specific TF in liver cells, demonstrating 
that our method also works in higher eukaryotes. 
3.3 Results  
We applied our method in two different organisms: budding yeast and mouse. For yeast, 
the data set we used [91] covers 108 haploid segregants from a cross between two 
haploid strains of Saccharomyces cerevisiae—a lab strain (BY) and a wild isolate from a 
vineyard (RM). It includes two-color DNA microarray measurements for each gene of 
the mRNA abundance in each individual segregant relative to a pooled reference 
consisting of equals amounts of mRNA from both parental strains, and genotyping 
information at 2957 genomic marker locations. The mouse data set consisted of gene 
expression levels in the liver cell lines of an F2 intercross population between C57BL/6J 
and DBA/2J (BXD) consisting of 111 animals [21], and the genotyping at 139 
microsatellite markers uniformly distributed over the mouse genome [92]. 
3.3.1 Inferring segregant-specific TF activities  
Figure 3.1 provides an overview of our computational procedure. As inputs, it requires: 
(i) the nucleotide sequence of the cis-regulatory region associated with each gene; (ii) a 
weight matrix for each TF, used to predict the strength with which the TF binds to 
each cis-regulatory region; (iii) a matrix containing continuous values, whose rows 
correspond to genes and whose columns contain the genome-wide mRNA expression 
profile of a particular segregant; and (iv) a genotype matrix containing binary values, 
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whose rows correspond to genetic markers, and whose columns specify from which 
parent each marker was inherited in a particular segregant. As cis-regulatory sequence, 
we used 600 bp upstream of each open reading frame. We previously demonstrated that 
when the binding specificity of a TF is known, quantitative changes in its regulatory 
activity can be inferred by performing genome-wide linear regression of differential 
mRNA expression on the predicted in vitro binding affinity of cis-regulatory regions 
[93]. The biophysical foundation that underlies this regression approach requires the 
binding specificity of each TF to be represented as a position-specific affinity matrix 
(PSAM)[94]. We used an existing compendium of position weight matrices (PWMs) for 
yeast TFs [95], converting each PWM to an approximate PSAM by assuming base 
frequencies to be proportional to relative binding affinities at each position within the 
binding site [80]. Each PSAM was then used to estimate the segregant-specific promoter 
affinity for all genes (Figure 3.1A). With only a few exceptions, these promoter affinity 
profiles are not correlated between TFs. This allowed us to estimate the segregant-
specific regulatory activity of most TFs in an independent manner. For each segregant, 
genome-wide linear regression of differential mRNA expression on segregant-specific 
promoter affinity for each TF was performed (Figure 3.1B). The coefficients from this fit 
represent protein-level TF activities, which we treat as a quantitative phenotype. 
Whenever the distribution of TF activity depends on the inheritance at a particular 
genomic position, this indicates the presence of an aQTL (Figure 3.1C). Details are 




Figure 3.1: Overview of aQTL approach. (A) We estimated genome-wide promoter 
binding affinity using 600bp upstream sequence of each open reading frame and position-
specific affinity matrix (PSAM). (B) Genome-wide promoter binding affinity was then 
used to infer transcription factor activity. For each segregant, the coefficients from 
genomewide linear regression of differential mRNA expression on promoter affinity for 
each TF represent protein-level TF activities. (C) We treat protein level TF activities as a 
quantitative phenotype in QTL mapping to detect aQTL region. Whenever the 
distribution of TF activity depends on the genotype of the specific markers at a particular 
genomic position, this shows high LOD score at these markers and indicates the presence 
of an aQTL. 
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3.3.2 TF activity is a highly heritable quantitative trait  
To establish that the TF activities inferred by our regression procedure are meaningful, 
we calculated their heritability h2 (see Materials and methods). Encouragingly, we found 
that the activity of 102 of the 123 TFs tested is heritable at a false discovery rate (FDR) 
of 5% corresponding to h2>80.4%. In general, the heritability of the inferred TF activity 
is higher than that of the mRNA expression level of the gene encoding the TF (Figure 
3.3). Figure 3.2 shows differences in TF activity between the BY and RM parental 
strains as estimated by applying the regression procedure of Figure 3.1 to the average 
differential mRNA expression profile between BY and RM [91]. Hap1p is the factor 
whose regulatory activity is the most strongly modulated between the BY and RM 
strains. Indeed, it is known that a Ty1 insertion in the HAP1 coding region occurs in BY 
and other derivatives of the lab strain S288C [96] and that this insertion is absent in RM 
[19]. Overall, 46 TFs are more active in RM, whereas 56 are more active in BY, at a 5% 
FDR. Merely comparing the two parental strains, however, does not reveal which loci are 
responsible for the differences in TF activity. Only genetic mapping to quantitative trait 




Figure 3.2: Differences in TF activities between the BY and RM parental strains. Shown 
are the t-values corresponding to the regression coefficients in a multivariate linear model 
that predicts genome-wide differential mRNA expression from predicted binding affinity 




Figure 3.3: Comparing the heritability of activity and mRNA expression level of TFs. (A) 
Histogram of heritability of TF activity. (B) Histogram of heritability of TF mRNA 
expression. (C) Scatter plot of heritability of TF activity versus TF mRNA expression 
 
Figure 3.4: Comparison of three different methods for mapping aQTLs. Shown are LOD 
score profiles across the HAP1 locus on chromosome XII obtained using (i) Composite 
Interval Mapping and two single markers methods, (ii) the parametric Welch’s t-test, and 
(iii) the non-parametric Wilcoxon-Mann-Whitney test.  
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3.3.3 Identifying aQTLs: genomic loci that modulate TF activity  
The regression procedure of Figure 3.1 takes into account prior information about the 
connectivity of the transcriptional network of the cell in a way that allows us to directly 
treat TF activity as a quantitative trait. To identify aQTLs for each TF, we used 
composite interval mapping (CIM) [97], which accounts for linkage between neighboring 
markers and has significantly better spatial resolution than single-marker methods 
(Figure 3.4). This is important, as even the aQTL regions detected using CIM typically 
encompass 20–30 genes, and our goal is to uncover trans-acting causal mutations in 
individual genes or even nucleotides. Figure 3.5 provides an overview of the TF-locus 
associations identified using our method. To control for multiple testing, we use a log-
odds (LOD) score threshold (red line in Figure 3.1C) corresponding to a 5% FDR (see 
Materials and methods). We identified a single aQTL for 55 and multiple aQTLs for 22 
of the 123 TFs analyzed. Together, the mapped aQTLs cover several dozen distinct 
genomic loci. Note that all aQTLs are by definition trans-acting from the point of view of 
the mRNA expression level of individual genes, as the trait analyzed is the ‘hidden' 




Figure 3.5: Overview of the trans-acting genetic modulators of TF activity mapped using 
our method. All transcription factors that have at least one significant aQTL region at a 
5% FDR are shown. Transcription factors are sorted according to the chromosomal 
position of their maximum LOD score. Putative causal gene assignments are indicated in 
green (local aQTL: TF encoded by gene in aQTL) or red (protein-protein interaction 





Figure 3.6: The effect of IRA2 allele replacement on TF activities. Comparing the 
average effect of IRA2 allele replacement in a BY or RM background on the activities of 
TFs (x-axis) with the LOD score for linkage to the IRA2 locus obtained using our aQTL 
method (y-axis). The red lines denote the LOD score and p-value thresholds 
corresponding to a 5% FDR 
 
3.3.4 Validation of aQTL-TF linkage using a IRA2 allele swap 
To the extent that aQTLs act independently, the regulatory consequences of allelic 
variation at a particular locus should be independent of the genetic background in which 
it occurs. To validate our method, we therefore analyzed gene expression profiles of 
allele replacement strains from a previous study [91]. According to our analysis, 
chromosome 15 contains an aQTL that influences the activity of several dozen distinct 
TFs (Figure 3.5). Among the 19 genes in this region is IRA2, which encodes a GTPase-
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activating protein that negatively regulates Ras proteins and thereby controls intracellular 
cAMP levels [98]. The coding region of IRA2 is highly polymorphic [91]. We analyzed 
the gene expression profile of a BY strain carrying the RM allele of the IRA2 coding 
region, and vice versa, and found that the activity of Adr1p, Cha4p, and Msn4p was 
significantly affected by the allele replacement (Figure 3.6; P-value 3.3 × 10−16, 1.1 × 
10−10, and 1.6 × 10−5, respectively, see Materials and methods). Each of these TFs was 
indeed predicted by our method to link to the IRA2 locus. Consistently, cAMP-dependent 
protein kinase is known to influence Adr1p activity [99] and regulate subcellular 
localization of Msn4p, which influences its activity [100]. Altogether, there are 30 TFs 
with an aQTL region containing the IRA2 gene. They do not all need to be influenced by 
the polymorphism(s) in its coding region; additional causal polymorphisms in nearby 
genes, modulating other subsets of the 30 TFs, may well exist. It is therefore not 
surprising that the activity of only 3 out of 30 TFs was significantly affected by 
the IRA2 allele replacement. On the other hand, we do not expect any TF whose activity 
doesnot link to the IRA2 locus to be affected by the allele replacement. Indeed, as can be 
seen from Figure 3.6, our method achieved 100% specificity in this regard: none of the 
93 TFs whose aQTL(s) do not contain IRA2 showed a change in regulatory activity. 
3.3.5 Novel trans-acting polymorphisms in transcription factor genes  
Of the aQTL linkages we detected, only four—those of Hap1p, Stb5p, Rfx1p, and 
Hap4p—are local (Figure 3.5, green boxes). The probability that a locus showing aQTL 
linkage encompasses the gene encoding the TF itself by chance is typically <1% (it 
equals the ratio of the number of genes in the aQTL and the total number of genes). 
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Therefore, whenever such local linkage happens, it is highly likely that the causal 
polymorphism resides in the coding region or regulatory region of the TF gene. The 
aQTL profile for Hap1p is shown in Figure 3.1C, and the polymorphism in HAP1 that 
gives rise to it was already discussed above. 
 Stb5p is a C2H2 zinc finger protein that serves as an activator of multidrug 
resistance genes [101]. A significant difference in Stb5p activity exists between the BY 
and RM strains (Figure 3.7A), and this activity is highly heritable (h2=95%). We 
detected highly significant local linkage (LOD score=10.84; Q-value=2.69 × 10−8) 
between Stb5p activity and the allelic status of the STB5 locus (Figure 3.7B). Alignment 
of the BY and RM protein sequences for Stb5p revealed five amino-acid mutations, all of 
which occur outside the DNA-binding domain. We found no nucleotide differences in the 
5′ and 3′ untranslated regions or <1 kb upstream of the transcription start site of STB5. 
Consistently, the mRNA expression level of the STB5 gene is not significantly correlated 
with the activity of Stb5p (r=0.18; P-value>0.05). Furthermore, CIM analysis of the 
mRNA expression level of the STB5 gene did not reveal any local eQTL linkage (Figure 
3.7C). The power of our aQTL approach is further underscored by the fact that no eQTL 
hotspot has been detected at the STB5 locus [19]. It will be interesting to further dissect 
the post-translational mechanism(s) by which the sequence differences between the BY 






Figure 3.7: local-aQTL for STB5. (A) Inferred activity of Stb5p in parental strains and 
segregants. The first and second columns show the activity of Stb5 in 6 replicates of a 
BY-reference comparison and 6 replicates of a RM-reference comparison. The third and 
fourth columns show the activity of Stb5p for segregants that inherited the BY and RM at 
the STB5 locus, respectively. (B) LOD score profile for the activity of Stb5p. *Locus 
including STB5 gene. (C) LOD score profiles for the expression level of STB5 gene. 
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 Rfx1p is a major transcriptional repressor of the DNA damage response. The RM 
allele of the RFX1 gene contains a premature stop codon. Consistently, genes whose 
promoter is predicted to be bound by Rfx1p tend to be more highly expressed in the BY 
strain than in the RM strain (Figure 3.2). 
 The last local aQTL we discovered was for Hap4p, a subunit of the heme-
activated, glucose-repressed Hap2p/3p/4p/5p CCAAT binding complex. Consistently, the 
mRNA expression level of the HAP4 gene is highly correlated with the activity of Hap4p 
(r=0.79). 
3.3.6 CDC28 antagonistically modulates Fkh1 and fkh2 
Chromosome II contains an ‘aQTL hotspot' whose allelic status influences the activity of 
no fewer than 15 distinct TFs (Figure 3.5), including Fkh1p and Fkh2p. The locus 
contains the CDC28 gene, which encodes a cyclin-dependent kinase. Phosphorylation by 
Cdc28p is known to regulate the activity of Fkh2 by promoting interaction with a 
coactivator [102]. On the basis of the aQTL mapping to the CDC28 locus in combination 
with high-throughput evidence of their physical interaction [103] with Cdc28p, we 
predict that Fkh1p is also post-translationally modulated by Cdc28p. The sign of the 
aQTL linkage to the CDC28 locus for Fhk2p is the opposite of that for Fkh1p (Figure 
3.8A): whereas the transcriptional targets of Fkp1p are more highly expressed in 
segregants carrying the BY allele at the CDC28 locus, the opposite is true for the targets 
of Fkh2p (Figure 3.8B). The same pattern holds for the inferred difference in TF activity 
between the two parental strains (Figure 3.2). The antagonism between Fkh1p and Fkh2p 
is consistent with previously observed differences in function between the two factors 
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[104, 105]. These two TFs have similar sequence specificity, and consequently their total 
promoter affinity profiles are correlated across genes (r=0.72). Nevertheless, we were 
able to detect the opposite influence of the CDC28 polymorphism on their activity 
because our method uses multivariate regression, which forces TFs with correlated 
promoter affinity profiles to compete for the same differential mRNA expression signal. 
When we analyze each TF separately using a univariate model, the CIM regression 
coefficients for Fkh1p and Fkh2p (incorrectly) have the same sign. This example 
underscores the importance of our affinity-based quantification of the matrix of 





Figure 3.8: CDC28 as a modulator of Fkh1p and Fkh2p. (A) Activity of Fkh1p and 
Fkh2p across all segregants. The activity of Fkh1p is negatively correlated with that of 
Fkh2p. The yellow dots correspond to segregants carrying the BY allele at the CDC28 
locus, the green dots to those carrying the RM allele. (B) Schematic diagram illustrating 
the antagonistic modulation of Fkh1p and Fkh2p by Cdc28p. While the transcriptional 
targets of Fkh1p are more highly expressed in segregants carrying the BY allele at the 
CDC28 locus, the opposite is true for the targets of Fkh1p. 
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3.3.7 An aQTL on chromosome VII controlling Zscan4 activity in mouse liver cells 
To determine whether our method could map aQTLs for mammalian TFs, we applied it 
to parallel genotyping and liver cell expression data for an F2 mouse population [21]. 
Weight matrices derived from protein-binding microarray (PBM) data for 104 mouse TFs 
were used [106]. The model we used to analyze the yeast segregants contains ‘cis' 
coefficients, which explicitly model changes in expression because of allelic variation in 
promoter sequence, in addition to the ‘trans' coefficient that model the changes in TF 
activity. However, we found that a simpler ‘trans-only' model performed equally well in 
terms of mapping aQTLs when applied to the yeast segregant data. This gave us 
confidence to use a ‘trans-only' model in mouse, where the density of markers is too low 
to assign gene-specific promoter sequences. We identified an aQTL for Zscan4, a TF 
containing four zinc finger domains and a SCAN domain, which is also known as the 
leucine-rich region [107] (Figure 3.9). Using a multivariate linear model to analyze the 
homozygous C57BL/6J (BB), homozygous DBA/2J (DD), and heterozygous (BD) 
genotype at the aQTL locus (Figure 3.9A), we found the behavior of the aQTL to be 
additive and show no significant dominant effect (see Materials and methods). A highly 
significant linkage (LOD score=10.8) with Zscan4 activity occurs between 43 and 66 cM 
on mouse chromosome 7 (Figure 3.9B). This region contains >500 genes, which makes 
it difficult to predict the causal polymorphism. Limited information is available about 
protein–protein interaction (PPI) for mouse, and we could not detect any direct 
interaction between genes within this region and Zscan4p. However, our result 
demonstrates that TF activity can also be inferred and mapped in mammalian cells using 
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our method, and provides a starting point for further dissection of trans-acting regulatory 
variation mediated by Zscan4p. 
 
Figure 3.9: aQTL of Zscan4p. (A) Inferred activity of Zscan4p across all F2 mouse 
population. Each column show the activity of Zscan4 in homozygous C57BL/6J (BB), 
heterozygous (BD), and homozygous DBA/2J (DD) mice at aQTL positions, 
respectively. (B) LOD score profile for Zscan4p. 
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3.4 Discussion  
We have presented a transcription-factor-centric method for identifying trans-acting 
genetic modulators of gene expression using parallel genotyping and mRNA expression 
phenotyping data. Our approach is based on the idea of treating the genotype-specific 
regulatory activity of each TF as a quantitative trait. It exploits prior information about 
the network of interactions between TFs and their target genes to infer genotype-specific 
TF activities from genome-wide measurements of mRNA expression. Our method has 
greatly increased statistical power to detect locus-TF associations. It is sensitive even to a 
relatively subtle influence of genotype-specific TF activity on mRNA expression because 
it is based on a statistical analysis across both genes and segregants. The fact that TF 
activity is not a gene-specific phenotype allows us to make the rather crude assumption 
that the strength of the regulatory connectivity between TF and target gene is 
proportional to in vitro promoter affinity. In reality, many of the predicted binding sites in 
promoter regions are not functional, due to complex interactions with nucleosomes and 
other chromatin-associated factors. It is remarkable that our method works in spite of this 
complexity. 
 Application of our aQTL method to a data set for 108 haploid segregants from a 
cross between two yeast strains [91] demonstrated a dramatic increase in statistical power 
to uncover the regulatory mechanisms underlying genetic variation in gene expression 
levels. We identified a total of 103 locus-TF associations, a more than six-fold 
improvement over the 17 locus-TF associations identified by several existing methods 
[19, 32, 34, 35, 91]. The total number of distinct genomic loci identified as an aQTL for 
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one or more TFs equals 31, which includes 11 of the 13 previously identified eQTL 
hotspots [91]. Thus, our method identifies 20 novel trans-acting polymorphisms: almost 
double the number of known such loci in yeast. For many of the eQTL hotspots, it also 
implicated several TFs not previously known to mediate the influence of these loci on 
genome-wide mRNA expression. 
 Our regression procedure fully accounts for post-translational regulation of TF 
activity at the protein level, as we do not use the mRNA expression level of either the 
gene encoding the TF or one its upstream modulators as a surrogate for regulatory 
activity. Indeed, the correlation between the protein-level regulatory activity of a TF and 
its expression at the mRNA level across a large number of experimental conditions in 
yeast was recently found to often be quite poor [86]. The present study confirms this 
observation: Only one third of TFs analyzed show a significant (<5% FDR) correlation 
between mRNA expression and activity. Moreover, only 12 of the 103 TF-locus 
associations could be confirmed when mRNA expression level was used as a proxy 
inferred protein-level TF activity. 
 We also applied our aQTL method to the earlier yeast segregant data set of [26]. 
This confirmed the dramatic increase in statistical power afforded by our approach. We 
detected a total of 79 locus-TF associations, which again is a more than six-fold 
improvement over the 14 locus-TF associations detected from these data by several 
existing methods [34, 35, 37, 38] combined. Furthermore, 28 of these 79 locus-TF 
associations were also detected using the data of [91]. This degree of reproducibility 
strongly validates our method: given that the number of possible such associations equals 
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the number of TFs (123) times the number of markers (~3000) divided by the average 
number of genes per locus (~20), we would expect this overlap to be ~0.4 by random 
chance. There is also no reason to expect complete overlap, as the data sets were similar 
but not identical. Indeed, although 13 eQTL hotspots have been identified in each 
respective data set, only 8 of these are the same [34, 91].  
 Our findings are consistent with previous observations [32] that most trans-acting 
variation in yeast does not map to TF genes, but to upstream modulators of TF activity. 
Indeed, of the total of 103 TF-locus associations shown in Figure 3.5 only four are local. 
We confirmed that HAP1 is directly affected by a sequence polymorphism, and 
discovered novel trans-acting polymorphisms in the TF-encoding geneSTB5, RFX1, 
and HAP4. Unexpectedly, our analysis revealed loci on chromosomes II and XV that are 
informative for a large number of TFs (‘aQTL hotspots'). We stress that this cannot be 
accounted for in terms of correlated profiles of promoter affinity across genes, as we 
found these to be largely independent between TFs. Rather, this phenomenon seems to 
point to one-to-many relationships between signal transduction pathways and TFs. For 
instance, our method predicts that genetic variation at the locus on chromosome II 
encoding the cyclin-dependent kinase CDC28 changes the activity of multiple cell cycle 
associated TFs (Ace2p, Fkh1p, Fkh2p, and Swi5p). At the same time, distinct 
polymorphisms at the same aQTL could be responsible for modulating different subsets 
of linked TFs. Evidence for this is our observation that allele replacement at the IRA2 
locus on chromosome XV only affected a small subset of the TFs whose activity is linked 
to this aQTL (cf. Figure 3.6). 
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 In an effort to uncover further specific molecular mechanisms underlying the 
aQTL linkages summarized in Figure 3.5 we supplemented our genetic analysis with 
knowledge about physical and genetic PPIs; see Materials and methods for details. The 
information provided by PPI and aQTL is highly complementary. On the one hand, aQTL 
linkage can only implicate relatively large genomic regions, not individual genes, as 
genetic modulators of TF activity. On the other hand, although PPI data can connect a TF 
to a putative modulator of its activity, it would be questionable to conclude that the 
interaction corresponds to a functional regulatory network connection without the strict 
causality and directionality associated with aQTL linkage. In all cases, the probability 
that a gene within the aQTL region encodes one of the direct interactors of the TF by 
chance is <3% (see Materials and methods). Therefore, most of these genes (aQTG) are 
expected to encode direct or indirect modulators of the TF's activity. We were able to 
implicate a non-coding polymorphism in the CDC28 gene as a plausible genetic factor 
underlying the major eQTL hotspot on chromosome II (in addition to the experimentally 
validatedtrans-acting polymorphism in the AMN1 gene in the same region [32]) and 
make a strong prediction that the functionally distinct cell cycle regulators Fkh1p and 
Fkh2p are modulated by the cyclin-dependent kinase Cdc28p in an antagonistic manner. 
 Extensive transgressive segregation has been previously identified for the 
expression levels of individual genes [26]. However, when we tested for the same 
phenomenon at the level of TF activity (see Materials and methods), we were only able to 
detect transgressive segregation for Ecm22p and Tec1p; in both cases, the effects of two 
aQTLs for same TF cancel each other in both parental strains, and no differential activity 
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between RM and BY could be observed (Figure 3.2). Presumably, much of the 
transgressive segregation at the level of individual genes is due to the fact that positive 
and negative contributions from different TFs can cancel each other. Our multivariate 
modeling of each individual gene's expression level in terms of the activity of multiple 
TFs accounts for such compensation explicitly, and hence the transgression is much less 
prevalent for aQTLs than for eQTLs. 
 In our approach, ‘phenotype space' is reduced from that of all genes to that of all 
TFs. Rather than mapping the measured mRNA expression level of individual genes to 
eQTLs, we map the inferred activity of each TF to ‘aQTLs.' This enhances statistical 
power in two distinct ways. First, it improves the signal-to-noise ratio for the quantitative 
trait itself, as the activity of each TF is estimated from the mRNA expression levels of its 
many targets. Second, the severity of the multiple-testing problem associated with QTL 
mapping because of the large number of marker/trait combinations is greatly reduced. 
Running in only seconds on a single processor, our algorithm is also computationally 
efficient. 
 It is important to emphasize that in our method the molecular identity of a TF is 
only defined through the PSAM that parameterizes its DNA-binding specificity. The 
sequence-to-affinity model for each TF needs to be specific enough to allow 
differentiation from all other TFs. We found that in the case of the budding yeast S. 
cerevisiae this condition generally holds. Given the rapid pace at which in vitro DNA-
binding data is currently being generated for mammalian TFs [106], together with the 
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demonstrated ability of regression-based models to infer TF activity in human cells [108], 
we expect application of our method also to be feasible in higher eukaryotes. 
 Taken together, our results underscore the value of explicitly treating TF activity 
as a quantitative trait from a systems biology perspective as a promising strategy for 
increasing the statistical power of genome-wide linkage and association studies. More 
generally, our method is applicable whenever a matrix of connection strengths between 
regulators and targets, independent of the phenotype matrix, is available as prior 
information. There are several directions in which this approach can be extended. First, 
the use of more sophisticated methods for causal gene identification [37, 109, 110] is 
likely to uncover additional molecular mechanisms. It will also be interesting to analyze 
to what extent the connectivity between the TF and their genetic modulators depends on 
the nutrient condition in which the yeast cells are grown [91]. Furthermore, aQTLs 
provide a novel vantage point for analyzing locus–locus interactions. Finally, it should be 
interesting to analyze to what extent genetic variation in steady-state gene expression 
levels because of post-transcriptional regulation of mRNA stability [94, 110] is amenable 
to dissection using the method introduced in this paper. 
3.5 Materials and methods  
3.5.1 Gene expression and genotyping data  
We analyzed genome-wide mRNA expression data from a study performed by [91], 
which used two-color cDNA arrays. The data (GEO accession number GSE9376) cover a 
genetic cross between two haploid yeast strains—a laboratory strain (BY4716) and a 
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natural isolate (RM11-1a). The data set includes six biological replicates of the BY 
parental strain, six replicates of the RM parental strain, and one replicate for each of 108 
haploid segregants grown in two different conditions, with glucose and ethanol as the 
carbon source, respectively. For the present study, we only used data for the glucose 
condition. The study used a reference design in which all hybridizations were performed 
using equal amounts of mRNA from both parents (BY and RM) grown in both conditions 
as a reference. Log2-ratios, averaged over a dye swap, were used for all further analysis. 
 For comparison, we also analyzed genome-wide mRNA expression data for yeast 
segregants from a cross between BY and RM strains (GEO accession number GSE1990) 
from an earlier study performed by [26]. Following these authors, we excluded ORFs 
rejected by [111]. The data set covers 6 biological replicates of the BY parental strain, 12 
replicates of the RM parental strain, and 1 replicate for each of 112 haploid segregants. 
The study used the BY material as a reference. Log2-ratios, averaged over the dye swap, 
were used for all further analysis. In addition, we averaged log-ratios for 13 ORFs that 
were spotted twice. Finally, we normalized each array by subtracting the mean log-ratio. 
For each of the segregants whose expression levels were determined, 2957 markers were 
genotyped by [26], who kindly made this data available to us. 
 We also analyzed previously published F2 mouse genome-wide expression data 
[21, 92](GEO accession GSE2008). The data set contains genome-wide oligonucleotide 
microarrays profiled using liver tissue from 111 F2 mice, which were constructed from 
two standard inbred strains, C57BL/6J and DBA/2J. The F2 mice fed an atherogenic diet 
for 4 months beginning at 12 months of age. This study used a common pool created 
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from equal portions of RNA from each of the samples as a reference. Following the 
previous study, expression changes between each sample and a reference were quantified 
as expression log10-ratios between normalized, background-corrected intensity values for 
the two channels. The F2 intercross mice were genotyped at 139 microsatellite markers 
uniformly distributed over the mouse genome. 
3.5.2 Genome sequence of BY and RM strains  
We obtained RM11-1a sequence data from the Broad Institute 
(http://www.broad.mit.edu) and BY4716 sequence data from the Saccharomyces Genome 
Database (SGD; http://www.yeastgenome.org). 
3.5.3 Defining genotype-specific promoter sequences 
To define genotype-specific promoter sequences, we first identified pairs of genes 
orthologous between BY and RM. We aligned coding sequences of RM genes to the BY 
strains using BLAST in Bioperl [112], and chose the best BLAST hits to identify the 
orthologous genes. Then, we obtained 600 bp upstream sequences of each orthologous 
pair to define BY and RM-specific promoter sequence. For segregants, we determined 
whether the promoter sequence of a particular gene was inherited from BY or RM strains. 
To this end, we first identified all genetic markers located within the 600 bp upstream of 
each open reading frame. If no genetic marker within 600 bp could be found, we selected 
the marker closest to the upstream region. The genotype of the selected markers was used 
to assign either the BY or RM promoter sequence to the gene. If multiple markers with 
inconsistent genotypes were selected, we discarded the gene. 
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3.5.4 Inferring segregant-specific TF activities  
We downloaded a collection of 124 position weight matrices (PWMs) from a study by 
MacIsaac et al. [95] (we excluded Hap3, as it has the exact same PWM as Hap5). Next, 
we used the convert2psam utility from the MatrixREDUCE v2.0 software package 
(see http://bussemakerlab.org) to convert each PWM to a position-specific 
affinity matrix (PSAM) [78, 113, 114]. Pseudo-counts equal to one were added to the 
PWM at each position, and the resulting base counts were divided by that of the most 
frequent base at each position to get an estimate for the relative affinity associated with 
each point mutation away from the optimal binding sequence [115]. The resulting PSAM 
collection was used to infer genotype-specific changes in TF activity. 
 The occupancy 
€ 
Nφg  of the upstream region 
€ 
Ug  of gene 
€ 
g  by transcription factor 
€ 
φ  depends on the nuclear concentration 
€ 
[φ] of the TF and on the landscape of binding 
affinity across 
€ 
Ug . Both these quantities are genotype-specific. At non-saturating 
concentrations of the TF, the occupancy in genotype 
€ 
G can be approximated by the 
product of concentration and affinity [78]: 
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Ngφ (G) ≈ [φ](G)Kφg (G) 
The total promoter affinity 
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Kφg (G) depends on the segregant-specific upstream sequence 
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Kgφi  represents the binding affinity (relative to the optimal DNA sequence) 
between transcription factor 
€ 
φ  and the DNA in a window of length 
€ 
Lφ  starting at position 
€ 
i  within 
€ 
Ug . Assuming independence between nucleotide positions, we approximate 
€ 
Kgφi 
by a product of position-specific relative affinities 
€ 
wφjb . Finally, 
€ 
bi(Ug )  denotes the base 
identity at nucleotide position 
€ 
i  within 
€ 
Ug . 
 We assume that when steady-state mRNA abundances are being compared 
between genotype 
€ 
G and reference genotype 
€ 
Gref , the expression log2-ratio for gene 
€ 
g, 
to linear approximation, is proportional to the difference in promoter occupancy: 
 
€ 
log2 [mRNAg ](G)( ) − log2 [mRNAg ](Gref )( )∝Nφg (G) − Nφg (Gref )
≈ [φ](G)Kφg (G) − [φ](Gref )Kφg (Gref )
= [φ](G) − [φ](Gref )( )Kφg (G) + [φ](Gref ) Kφg (G) −Kφg (Gref )( )
 
All total promoter affinities are known, so we can use the differential mRNA abundances 
to estimate coefficients 
€ 
β cis ≡ [φ](Gref )  and 
€ 
β trans ≡ [φ](G) − [φ](Gref ). This motivated us to 
fit the following multivariate linear model to each segregant: 
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Here 
€ 
ygs represents mRNA expression log-ratios for gene 
€ 
g  in segregant 
€ 
s.  For the 
segregant data of Smith et al. [116], whose used a pool of equals amounts of parental 
strains as their reference sample, 
€ 
Kφg refequals the average of BY and RM promoter 




Kφg refequals the BY promoter affinity. The intercept 
€ 
β0s absorbs any normalization 
differences that may occur. The genomewide affinity profiles for several PSAMs are 
highly correlated (e.g., Msn2 and Msn4, Ino2 and Ino4). To avoid any problems resulting 
from such multicollinearity, we used ridge regression, which minimizes the residual sum 
of squares subject to a penalty proportional to the L2-norm of the coefficients, and gives a 
slightly biased but more precise estimator of coefficients than ordinary least squares 
[118]. We also fit the above model in “trans-only” mode (
€ 
β cis ≡ 0 ). 
 To infer segregant-specific TF activities in mouse, we downloaded PWMs 
defined by Badis et al. [106] who used protein binding microarray (PBM) technology to 
determine the in vitro DNA binding specificities of 104 different mouse TFs. We 
estimated PSAM and total promoter affinity from PWMs using 1000bp upstream 
sequence of C57BL/6J strain by the same procedure explained above. We obtained 
C57BL/6J mouse genome sequence from UCSC Genome Browser 
(http://genome.ucsc.edu/).  
3.5.5 Heritability  
We calculated the heritability of the activity of each TF as follows: 
€ 







2  are the variance of the linear regression coefficient from the ridge 
regression across the segregants, and the pooled variance of the parental strains, 
respectively. To determine the statistical significance of the heritability, we performed 
ridge regression after independent random permutation of expression log-ratios (parents 
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and segregants combined) for each gene (1,000 samples) and used the resulting empirical 
null distribution to compute a false discovery rate (FDR). 
3.5.6 aQTL mapping in yeast  
To detect significant genetic contributions to TF activity by specific loci, we performed a 
split of the segregants by each specific marker and tested for a difference between the 
two distributions of ridge regression coefficients using Welch's t-test and the non-
parametric Wilcoxon–Mann–Whitney test. We also used CIM, which uses multivariate 
regression on multiple markers for increased precision of QTL mapping [97], as 
implemented in the R/qtl package [119]. Statistical significance was determined by 
performing independent random permutation of expression log-ratios (segregants only) 
for each gene. The FDR corresponding to a given LOD score threshold was computed as 
the ratio of the number of linkages above threshold averaged over 20 randomized data 
sets, and the number of transcripts with detected linkage. We also estimated the FDR 
using the standard Benjamini-Hochberg procedure [120]. For the CIM method, a 5% 
FDR based on the empirical permutation test corresponded to a LOD score >4.49. 
3.5.7 aQTL mapping in mouse 
In the case of mouse data analysis, aQTL mapping was conducted using a linear model. 
First, we constructed explanatory variables for the additive and dominance terms for each 
marker from the estimated genotype probabilities and used them in the regression 
analysis. Linkages were identified by comparing the likelihood, maximized as a function 





trans= β0 + βφ
addXmsadd + βφdomXmsdom  
to the likelihood for the null model 
€ 
βφs




represents the TF activity as estimated using the affinity-based model defined above in 
“trans-only” mode (
€ 
β cis ≡ 0 ). The independent variables
€ 
Xmsadd  (taking values 0, 1, and 2, 
for (diploid) genotypes BB, BD, and DD, respectively) and 
€ 
Xmsdom  (taking values 0, 1, and 
1, for the same respective genotypes) represent additive and dominant terms for each 
marker respectively. The LOD score was defined as the log10 of the likelihood ratio 
between the two models. The FDR was computed using the same procedure described 
above; an FDR <5% based on empirical permutation test corresponded to a LOD score 
>4.21. 
3.5.8 Protein-protein interaction data 
To identify putative causal genes from the aQTL regions of each specific TF, we used 
three different types of protein-protein interaction data: (i) physical and genetic 
interactions in the BioGRID database [121], (ii) interactions between chromatin 
modifiers and associated TFs [122], and (iii) kinase-TF interactions [123]. We computed 
the expected number of direct interactors among the genes in the aQTL region for a 
specific TF based on the total number of interactors of the TF genomewide, the number 
of genes in the aQTL, and the total number of genes. Statistical significance was 
computed using Fisher's exact test. 
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3.5.9 Validation of predicted locus-TF association  
We downloaded gene expression profiles obtained by Smith et al. [116] for a strain 
carrying the RM allele of IRA2 in the BY4742 background (RM@IRA2), a strain 
carrying the BY allele of IRA2 in the RM11-1a background (BY@IRA2), and six 
replicates each of the BY and RM parental strains (GEO accession number GSE9376). 
We only used the date for cells grown in glucose as the carbon source. The reference 
sample used in all cases was pooled parental mRNA (see above). Therefore, to obtain an 
estimate for the differential expression between RM@IRA2 and BY, we subtracted the 




























and performed multivariate (ridge) regression of these values on the BY promoter 
affinities for all TFs. We also performed the equivalent analysis where the roles of RM 
and BY were reversed. Finally, to average over strain background, we took the difference 
between the two regression coefficients for each TF to be our statistic for differential 
activity. To determine statistical significance, we performed 1,000 random permutations 
of all genes to determine the standard error of an empirical null distribution, and used it 




Chapter 4                                                         
Applications of the aQTL method   
Our aQTL approach [90] is generally applicable whenever a matrix of connection 
strength between regulators and targets, independent of the phenotype matrix, is available 
as prior information. In collaboration with other Bussemaker lab members, I have 
extended this approach to other biological contexts: (i) the promiscuous binding of TFs to 
high-occupancy target (HOT) regions and (ii) post-transcriptional regulatory networks.  
4.1 Transcriptional factors dynamically congregate at non-coding RNA 
gene in Saccharomyces cerevisiae 
This section has been adapted from a manuscript co-authored by Lucas D. Ward, Junbai 
Wang, Eunjee Lee, and Harmen J. Bussemaker, which is currently in revision. My 
contribution to this work was to perform QTL mapping of the amplitude of the hotspot 
phenomenon for Ste12p for yeast segregants data (Figure 4.5). 
4.1.1 Introduction  
A canonical description of transcriptional regulation involves the binding of transcription 
factors (TFs) to cis-regulatory promoter and enhancer elements, resulting in recruitment 
of the RNA polymerase complex. However, whole-genome studies of TF binding have 
revealed that affinity of DNA for a TF is not sufficient for occupancy by TFs [124-126]. 
A number of mechanisms constrain the binding of TFs to only a subset of the sites that 
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genomic affinity alone would predict, such as chromatin state [127] and variability in 
local TF concentration [128]. 
 Perhaps more surprising has been the recent discovery of genomic loci at which 
many TFs congregate despite the underlying DNA sequence having affinity for only a 
small subset of them.  The evidence of such TF colocalization hotspots, or High-
Occupancy Target (HOT) regions, was seen in Drosophila melanogaster TFs [129]., C. 
elegans genome [130], and mouse embryonic stem cells [131]. A number of previously-
proposed mechanisms are consistent with TF colocalization, including multifunctional 
“transcription factories” or enhanceosomes [132] cross-linked by chromatin loops, a 
locally permissive chromatin structure [133, 134]. A feature shared by both organisms is 
that hotspots are associated with increased expression at neighboring genes, but are often 
located far from traditionally-defined proximal promoters. 
 The present study was motivated by the fact that, although much more extensive 
genome-wide protein location data has been collected in yeast than in higher eukaryotes 
[135-137] no analogous colocalization of sequence-specific regulators has been observed. 
Significantly, however, in the large-scale compendia by Lee et al. and Harbison et al., the 
authors normalized across arrays for each probe to account for biases in the 
immunoprecipitation reaction. Clearly, this normalization would have effectively 
removed the evidence for any true genomic hotspot pattern shared by many TFs. We 
therefore performed a detailed re-analysis of the original microarray data in which we 
have omitted the probe-specific normalization step. A pattern of ubiquitous TF binding at 
many probed regions was immediately apparent. Remarkably, unlike in fly and mouse, 
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these yeast hotspots are not associated with sequence-predicted affinity for any of the TFs 
involved. Rather, sequence and functional analysis reveals that the most significant 
features of co-occupied probed regions are: (i) the extent of nucleosome depletion and (ii) 
the proximity to noncoding RNA genes, the majority of which encode tRNAs and 
snoRNAs. Additionally, the TF colocalization hotspots are occupied chiefly in rich-media 
(YPD) conditions. The phenomenon is abrogated in the majority of environmental 
perturbation and stress conditions, indicating that the hotspots are a regulated biological 
entity. Supporting this hypothesis, we show that genetic variation at the locus encoding 
the regulatory gene RIM15 is associated with the amplitude of the hotspot effect.  
4.1.2 Results 
4.1.2.1 A majority of TFs preferentially immnuprecipitate with ncRNA genes, not at 
their target genes  
Because we were interested in finding loci that were bound by many TFs, we first 
considered the ChIP fold-enrichment (FE) of the 195 TFs profiled in rich media (YPD) 
for each probed region, using the median log2 fold-enrichment (MFE) as a measure of co-
occupancy. Surprisingly, the distribution of co-occupancy across probes was skewed 
heavily to the right (Figure 4.1A), suggesting that a subset of the probed regions was 
occupied by many factors. To systematically determine whether specific genomic 
features were associated with co-occupancy, we tested whether the distribution of MFE 
for probes corresponding to each annotated genomic feature was different from that 
corresponding to the rest of the genome. The most significantly co-occupied were the 514 
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probes corresponding to ncRNA genes (difference of means 
€ 
ΔM  = 0.27; p = 6.9 x 10-161, 
Student’s t-test; p < 2.2 x 10-16, Wilcoxon-Mann-Whitney test). The more specific 
ncRNA categories of tRNAs, snoRNAs, and snRNAs were all significantly co-occupied 
as well. 
 MacIsaac et al. [95] combined ChIP data with motif analysis and comparative 
genomics to define which promoter regions correspond to direct target genes for each 
yeast TF. We were interested in the extent to which these targeted regions were occupied 
according to our reanalysis of the data, and how this occupancy compared in magnitude 
to the occupancy we discovered at ncRNA genes (see Methods). We found that 
occupancy at ncRNA genes was typically on the same order of magnitude as the 
occupancy at annotated targets (Figure 4.1B).  Of all TFs, 47 significantly occupied both 
the ncRNA loci and their annotated targets, while 28 significantly occupied ncRNA 
genes but not their annotated targets, and only three significantly occupied their 
annotated targets but not ncRNA genes. 
4.1.2.2 Co-occupied loci are nucleosome-depleted 
To explore other relationships between genome annotation and TF co-occupancy, we 
looked for Gene Ontology (GO) enrichment. For every GO category, we compared the 
distribution of MFE within probes corresponding to promoters of genes in that category 
with the rest of the probes using both a t-test and a Wilcoxon-Mann-Whitney test. The 
most enriched GO category is genes encoding components of the cytosolic ribosome (t = 
12.3, p = 5.5 x 10-20). Because ribosomal protein (RP) promoters are known to be 
particularly active [138], we were interested in whether nucleosome depletion at these 
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promoters was making them more susceptible to nonspecific binding by TFs. Indeed, we 
found that MFE is strongly anticorrelated with nucleosome occupancy (Pearson r = –





Figure 4.1: Detection of TF co-occupancy. (A) Distribution of TF co-occupancy at 
probes, defined as median log2 fold enrichment (MFE) across all analyzed rich media 
experiments from Harbison et al. [135].  (B) Occupancy of TFs at their annotated target 
regions and at ncRNA genes. The occupancy at both is expressed as , the difference 
between the mean log2 fold enrichment of the probes in question and the mean log2 fold 
enrichment of all other probes. Significant occupancy is defined as described in Methods. 
(C) TF co-occupancy vs. nucleosome occupancy. Plotted as a black line is a fit of all the 
data to a linear model y = ax + b, where a = -0.16 and b = 0.003 (r = -0.31). RP promoter 
probes are colored blue and ncRNA gene probes colored red. Note that both RP 
promoters and ncRNA genes are significantly co-occupied as well as nucleosome 
depleted. Residuals corresponding to ncRNA gene probes are higher than residuals 
corresponding to RP promoter probes (t = 11.8, p = 1.2 x 10-25). 
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4.1.2.3 Co-occupancy at ncRNA genes is largely eliminated in stress conditions 
So far, our analysis has been restricted to rich media (YPD) conditions. It is known that 
the nuclear localization of many TFs is altered in stress conditions [139]. Examining 
ncRNA loci in stress conditions reveals dramatically reduced co-occupancy (Figure 4.2). 
Using the median TF occupancy across all non-YPD conditions, the elevation in co-
occupancy at ncRNA genes drops from 
€ 
ΔM  = 0.25 to 
€ 
ΔM  = 0.03. To further investigate 
this general observation by focusing on occupancy of individual TFs in their rich media 
and stress conditions. For each particular stress-TF combination, we calculated the 
occupancy at ncRNA genes relative to all other probes (Figure 4.3). As expected from 
our pooled analysis, in the majority of stress conditions the occupancy at ncRNA genes is 
greatly reduced. The most notable example of this is Ste12p, which occupies ncRNA 
genes upon exposure to alpha mating factor, but not in the absence of alpha factor or in 
the presence of 1-butanol. Dig1p, which is also associated with the mating response, 
behaves differently: it does not occupy ncRNA genes in rich media, and avoids them in 
the presence of alpha mating factor and 1-butanol.  
 
Figure 4.2: condition specific co-occupancy at ncRNA genes. TF co-occupancy, defined 
as the median log2 ChIP-chip fold enrichment (MFE), as a function of distance to the 
nearest ncRNA gene. (A) MFE across YPD experiments from Harbison et al. [135] (B) 




Figure 4.3: Condition specificity of occupancy at ncRNA gene. (A) Each row is a TF, and 
experimental conditions for that TF are plotted on the same row with letters indicating the 
condition. Conditions are: “Y”, rich media; “S”, sulfometuron methyl; “R”, rapamycin; 
“H”, hydrogen peroxide; “1”, 1-butanol; “A”, succinic acid; “G”, galactose; “V”, vitamin 
deprived medium; “M”, alpha mating factor; “F”, raffinose; and “P”, phosphate deprived 
medium. Occupancy is expressed as ΔMˉ , the difference between the mean log2 fold 
enrichment of ncRNA gene probes and the mean log2 fold enrichment of all other probes. 
(B) Leu3p, Kss1p, Ste12p, and Mot3p occupancy at ncRNA genes in rich media vs. 
sulfometuron methyl treatment. For each factor and conditions, an empirical cumulative 
distribution function is shown contrasting the distribution in log2 fold enrichment (FE) 




Figure 4.4: ChIP-Seq validation. Density of Ste12p ChIP-seq reads relative to the 
genome-wide coverage for the two parents tested under exposure to alpha mating factor 
in Zheng et al [140] and the strain tested under pseudohyphal growth conditions in 
Lefrancois et al. [141]. 
 
4.1.2.4 The RIM15 locus genetically modulates the degree of Ste12p targeting to 
ncRNA genes 
In spite of the fact that ChIP-Seq is currently the state of the art in genomic protein 
mapping, only a handful of factors have been assayed in yeast. For validation purposes, 
we compared three Ste12p ChIP-Seq datasets, one of which was performed in 
pseudohyphal conditions and two in exposure to alpha mating factor [140, 141]. Both 
showed enrichment near ncRNA genes, although the magnitude was greater during 
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exposure to alpha mating factor, consistent with the experiments of Harbison et al. 
(Figure 4.4). Zheng and colleagues profiled Ste12p occupancy in two diverged yeast 
strains, S96 and HS959, as well 43 genotyped segregants derived from a cross between 
these strains, in order to infer cis- and trans-regulatory polymorphisms affecting binding 
of the factor. To quantify the amplitude of the hotspot phenomenon for Ste12p in each 
segregant, we determined the fraction of ChIP-Seq reads mapping to within 100 bp of a 
ncRNA gene. Mapping this fraction as a quantitative trait, we found that highly 
significant linkage (LOD score = 6.08) with the hotspot effect for Ste12p occurs on 
chromosome VI (Figure 4.5). This locus contains three genes, one of which is RIM15. 
The regulatory kinase Rim15p is known to integrate signals from several distinct 
nutrient-sensing pathways (PKA, TORC1, Sch9, and Pho85-Pho80) and be required for 
entry into the stationary (G0) phase mediated by transcription factors Msn2/4 and Gis1 
upon nutrient deprivation [142, 143]. This is consistent with our observation that the 
hotspot effect for Ste12p is condition-dependent, and suggests that genetic variation in 
the RIM15 gene is a plausible modulator of hotspot behavior for Ste12p. Alignment of 
the S96 and HS959 protein sequences for Rim15p reveals that the RIM15 allele from 
strain HS959 encoded five amino-acid changes, four of which are non-conservative when 




Figure 4.5: QTL profile. Manhattan plot of genome-wide association between genotype 
and hotspot behavior identifying the RIM15-containing locus.  
4.1.3 Discussion  
4.1.3.1 Possible mechanisms underlying the dynamic targeting of ncRNA gene by 
TFs 
Several lines of cytological evidence from mammalian cells suggest that transcription by 
polymerase II occurs at nuclear foci comprising many polymerase molecules and 
transcription factors, termed “transcription factories” [132]. If such factories exist in 
yeast, it is conceivable that nucleosome-free regions and ncRNA genes – which are 
associated with high levels of transcription (by polymerase II and I/III, respectively) – are 
in close proximity to multiple TFs as a result of transcription factories. Consistently, it 
was recently discovered that Pol II-associated transcription factors tightly associate with 
Pol III-transcribed genes in human cells [144].  
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4.1.3.2 Yeast as a platform to genetically dissect TF colocalization  
Although hotspot behavior is familiar to investigators performing ChIP in metazoans, it 
had not been previously recognized in yeast, which is the most genetically tractable 
model eukaryote. Our analysis of the Ste12p data by Zheng and colleagues [140] reveals 
an association between polymorphisms in the RIM15 gene and localization of Ste12p to 
ncRNA genes during exposure to alpha mating factor. Multiple nutrient-sensing 
pathways converge on the Rim15p regulatory kinase, which regulates entry into the G0 
phase and mediates calorie restriction-dependent life span extension [142, 143, 145]. 
Based on this previously observed function of Rim15p in combination of our analysis of 
the Ste12p ChIP-seq data [140], we were able to implicate polymorphisms in the RIM15 
gene as a plausible genetic factor underlying the hotspot behavior for Ste12p. Whether 
RIM15 is uniquely associated with Ste12p localization or is a general regulator of TF 
colocalization remains to be determined. The ability of yeast ncRNA genes to serve as a 
model for the hotspot behavior of TFs opens the door for further genetic screens and 
biochemical validation. 
4.1.4 Methods and Materials  
4.1.4.1 Processing of raw ChIP-chip data  
The original raw ChIP-chip data [135, 136] were obtained from ArrayExpress 
(http://www.ebi.ac.uk/microarray-as/ae/) using accession numbers E-WMIT-1 and E-
WMIT-10, respectively. Protocol information for each array (which dye was IP vs. WCE, 
experimental conditions, etc.) was extracted from the files E-WMIT-1.sdrf.txt and E-
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WMIT-10.sdrf.txt, available in the directory http://www.ebi.ac.uk/microarray-
as/ae/download/. Raw intensity information was downloaded from the tab-delimited text 
files in E-WMIT-1.raw.zip and E-WMIT-10.raw.zip available in the FTP directory 
specified within the aforementioned text files. The column headers in all of these text 
files were found to be corrupted. Therefore, they were split between nine different 
formats. Each format was manually curated to locate the correct median foreground and 
background red and green intensity columns, using the presence of a background-
subtracted log ratio column as a validation. Raw intensities were loaded into R and Loess 
normalization was performed on each array (to account for dye-specific response 
functions) using the normalizeWithinArrays function of the limma package [146], 
resulting in an M (relative intensity) and A (absolute intensity) value for each spot on 
each array. A number of the arrays were found to have very low variance in their log 
ratios; arrays with a variance in M after Loess normalization less than 0.05 were 
discarded. Four summary values were calculated for each probe: a median log ratio (M) 
and intensity (A) signal across all rich-media (YPD) arrays, and a median log ratio (M) 
and intensity (A) across all stress arrays. Additionally, for every experimental condition 
for which multiple replicates were available, a median M and A value across replicates 
was calculated. The same processing was applied to ArrayExpress data from assaying 
rabbit IgG control, no-antibody control, and kinase occupancy by tiling array [72, 147], 
which we used for validation. 
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4.1.4.2 Comparison of occupancy at annotated targets and at ncRNA genes 
Annotated targets for each TF were defined as probes that overlapped or were 
neighboring (within 100 bp of) regions reported by MacIsaac et al. [95] within their p-
value threshold of 0.005. After discarding probes that were annotated both as ncRNA 
probes (according to the criterion described above) and as TF targets, we compared the 
mean log2 fold enrichment among ncRNA probes and among annotated targets with that 
of all other probes. A significant difference in means was defined as a t-test passing a p-
value threshold of 0.05, Bonferroni corrected for the number of tests. 
4.1.4.3 Gene Ontology analysis  
Functional enrichment of probes by Gene Ontology (GO) categories [148] was 
determined using the T-profiler algorithm [149], implemented using the YEAST package 
from the BioConductor platform within the R programming environment [150]. 
4.1.4.4 Regression analysis of gene annotation, nucleosome depletion, and co-
occupancy 
A linear regression was performed between nucleosome occupancy [151] and MFE 
across all probes. Residuals corresponding to ncRNA probes and all other probes were 
then compared using a t-test. Residuals were also analyzed for correlation with predicted 
affinity for TFs as described above. 
4.1.4.5 ChIP-seq analysis 
ChIP-seq data from Lefrancois et al. [141] and Zheng et al. [140] were downloaded from 
Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo). These data include 
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mapped peaks, but not genome-wide mapping of reads; therefore, read alignment results 
from ELAND were downloaded and processed using MACS [152] as described by the 
authors in order to obtain a genome-wide landscape of binding, in 10-bp bins. Distances 
from these bins to ncRNA genes were measured using the SGD genome annotation 
described above and BEDTools [153]. Bins not overlapping an ncRNA gene with a 
distance between 1 and 100 bp of an ncRNA gene were considered hotspots, and a 
quantitative trait for Ste12p localization to hotspots was defined as the ratio of reads 
mapping to this region to the total number of reads. This quantitative trait was calculated 
for both parents and each of the segregants for linkage analysis. 
4.1.4.6 QTL analysis 
To detect genetic contributions to the variation in hotspot behavior for Ste12p by specific 
loci, we used 55958 markers genotyped for 43 segregants from previous studies [140, 
154]. Following these authors, we removed 2498 markers with fewer than five 
occurrences of either parental genotype and grouped the neighboring markers with the 
same genotype distribution across segregants, which resulted in 2592 non-redundant 
markers. We performed Composite Interval Mapping (CIM) of Quantitative Trait Loci 
(QTLs) as implemented in the R/qtl package [119], which uses multivariate regression on 
multiple markers for increased precision [97]. Statistical significance was determined by 
performing 50 independent random permutations for each segregant. The FDR 
corresponding to a given LOD score threshold was computed as the ratio of the average 
number of markers above threshold and the number of markers for which linkage was 
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detected. A 5% FDR based on the empirical permutation test corresponded to a LOD 
score greater than 4.70. 
4.2 Harnessing natural sequence variation to dissect post-transcriptional 
networks in yeast  
This section has been adapted from a manuscript co-authored by Mina Fazlollahi, 
Eunjee Lee, Xiang-Jun Lu, Maria Pilar Gomez-Alcala and Harmen J Bussemaker. It will 
be submitted for publication in the near future. For this work, Mina Fazlollahi applied 
the aQTL software that I developed to the regulation of mRNA stability by RNA-binding 
proteins. 
4.2.1 Introduction 
Regulation through post-transcriptional activities of RNA binding proteins (RBPs) is 
critical mechanism for a living cell to control the mRNA levels. It includes assembly, 
edition, localization and stability of RNAs. However there have been more studies, which 
focus on DNA biding factors and their interaction network. Detecting binding motifs 
associated with RBPs are challenging due to more complicated structure of RNAs. 
 In this study, we searched for potential regulatory elements in mRNA sequences 
that are recognized by diverse RNA-binding proteins. We used a similar approach by [78] 
which searches for binding sites in the form of sequence-specific affinity matrices 
(PSAMs). We use REDUCESuite package (more specifically MatrixREDUCE software) 
to discover binding motifs. We then used these obtained PSAMs to score mRNA 
sequences. These score act as prior information for our QTL analysis. Together with the 
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mRNA differential expression levels for the every member of the population, we can 
infer the activity levels of the RBPs for every individual. We treated these activity levels 
as quantitative trait to discover loci modulating them as used in [90]. 
 With our PSAM finding analysis we were able to obtain known binding motifs for 
15 various RBPs and novel motifs for Scp160p, Sik1p and Tdh3. For the activity QTL 
(aQTL) analysis we recovered a known locus that contains MKT1 gene, which is shown 
to modulate Puf3p interaction with its targets [110]. Interestingly, we found that 
depending on Puf3p interaction with 5ʹ′ or 3ʹ′ UTRs of its target, there are different loci 
regulating its activity. For 5ʹ′ UTRs, we found a locus on chromosome 2 that contains 
POP7 gene. 
4.2.2 Results 
For the PSAM search, we used RNA imunoaffinity purification [155] including total of 
132 IP experiments for 45 different RBPs and for the aQTL search we used [91] 
including mRNA expression levels for 108 segregants obtained by a genetic cross 
between two haploid Saccharomyces cerevisiae strains: BY (laboratory strain) and RM (a 
wild isolate form a vineyard in California).  
4.2.2.1 PSAM search  
We used MatrixREDUCE software form REDUCESuite package that takes as inputs the 
nucleotide sequences and RBP binding data. To reduce the effect of outliers, we 
transformed the binding data into the quantiles of the ranks for each IP experiment, thus 
transforming it into a normally distributed data. As for sequences, we used the 
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annotations from [156] and extracted 5ʹ′ and 3ʹ′ untranslated regions (UTRs), open reading 
frames (ORFs) and whole mRNA nucleotide sequences in yeast. For every RBP, we 
performed our genome-wide motif search on whole mRNAs, ORFs, 5ʹ′ and 3ʹ′ UTRs 
separately due to different binding sites for the cases that the protein prefers to bind 
directly or indirectly.   
 We optimized these PSAMs by adding flanking sides (maximum of one 
nucleotide added to either sides at every optimization iteration) to capture any low 
specificity sites that were not captured during our training step. Out of 45 proteins, As a 
results, we were able to obtain PSAMs for 20 different RBPs. 
 We checked the correlation between 132 IP experiment and affinity of each 
mRNA segment separately and only accepted the RBP- mRNA region combination that 
is exclusively correlated to its own RBP binding experiments (specificity test). Figure 
4.6A shows the PSAM logos for 15 out of 20 PSAMs that passed the specificity test. 
Figure 4.6B shows all the 25 RBP-mRNA region combination that passed the specificity 
test. There was an exception with Scp160p-ORF where the affinity is slightly more 
correlated to Bfr1p IP experiment (green dots) However Bfr1p is reported to associate 
with cytoplasmic mRNP complexes containing Scp160p [157]. We observe that there is a 
large gap between the relevant IP experiments (red dots) and the rest of the IP 
experiments (blue dots) for the affinity of 3ʹ′ UTR of Pub1p, Puf2p, Puf3p, Puf4p and 





Figure 4.6: RBP PSAMs. (A) Recovered and discovered RBP PSAMs logos. These 15 
PSAMs passed cross-validation and specificity tests. (B) Scatter plot for the factors 
specificity test where the Pearson t-values of univariate linear fit coefficients between 
132 RBP binding experiments and 25 selected PSAM-sequence combinations are 
presented. Only the factors with at least one self RBP IP experiment t-value (red dots) 
appearing at the top are shown. The only exception is for Scp160 (ORF) where we have a 
higher correlation to Bfr1p binding data (green dots). We accepted this PSAM, since 

























































































































































































































































































































































































































4.2.2.2 Inferring RBP activity and linkage analysis  
We used segregant-specific genomewide mRNA expression levels to predict RBP 
activity variation among 108 yeast segregants. For each of 25 RBP-mRNA regions, we 
first scored all of the genes by calculating the affinity of the PSAM using the chosen 
sequence (whole mRNA, UTRs or ORFs). Then we performed multivariate regression 
between all 25 factors affinities and each segregant mRNA expression data. We 
considered the coefficients of the regression as the quantitative representation of the RBP 
activities. We used composite interval mapping (CIM) [97] to find aQTL for each factor. 
To correct for multiple testing, we calculated the lod-odds (LOD) score threshold for 1% 
false discovery rate (FDR) level by 200 permutations. 
4.2.2.3 aQTL discovery  
Using mRNA expression levels data to infer the RBPs activity levels, we were able to 
detect significant aQTLs for 7 different RBPs (9 factors) where 1 of them has been 
previously reported (Figure 4.7) and the rest are new.  
Recovered aQTL for Puf3p 
Our method was able to recover a locus on chromosome 14 linked to MKT1 for Puf3p 
when we calculated its activity using 3ʹ′ UTRs sequences (Figure 4.7C). This locus was 
previously discovered computationally and experimentally by [110].  They have 
suggested that MKT1 regulates p-body abundance, which consequently regulates Puf3p 





Figure 4.7: aQTL profile of RBPs. A-F) Results of the trans-acting genetic modulators of 
RBP activity of Puf3p and Puf4p mapped using our aQTL method. Significant aQTL 
regions at a 1% FDR level are marked calculated using 200 independent permutations of 
expression data. For each factor, these regions survived after filtering out for the 3 groups 
of genes mentioned earlier. The red line represents the LOD score threshold for the 1% 
FDR level. Sections A-C show aQTL profile for Puf3p activity and D-F for Puf4p 
activity on 5′ UTRs, ORF and 3’ UTRs respectively. We were able to detect 2 novel 
trans-acting loci (chr2 and chr11) and a previously reported one (chr14) For Puf3p. Puf4 
activity showed a significant linkage to a locus on chr15 irrespective of which mRNA 
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Puf3p activity modulated differently depending on binding to 5ʹ′  UTRs and 3ʹ′  UTRs 
Previously it was mostly known that Puf3p interact with the 3ʹ′ UTRs of its targets and no 
evidence of functional interaction with the mRNAs 5ʹ′ UTRs has been reported. As 
mention above, Puf3p activity is modulated through a locus on Chr14 when considering 
its binding to 3ʹ′ UTRs of its targets. However considering Puf3p binding to 5ʹ′ UTRs, we 
were able to link its activity level variation to a locus on Chr2 (Figure 4.7A). This region 
contains POP7, which is reported to have positive genetic interaction with Puf3p [158]. 
These findings indicate that the activity modulation of Puf3p is linked to different 
genomic locations and networks depending on where it binds to the mRNA.  
Puf4p activity modulation is independent of where on target mRNA it binds 
Puf4p aQTL profile is shown in Figure 4.7D-F. Whether Puf4p binds to 5ʹ′ UTRs, ORFs 
or 3ʹ′ UTRs of its targets, its activity regulation is controlled by a locus on chr15. This 
locus contains REX4 and BRX1. Both of them are involved in pre-rRNA possessing and 
ribosome assembly. It is known that Puf4 interacts with mRNAs encoding nucleolar 
rRNA-prossessing factors. 
4.2.3 Methods and Materials    
4.2.3.1 Experiment data sets 
For our RBP PSAM search, we analyzed genome-wide RNA imunoaffinity purification 
data, which was performed for 45 different RNA binding proteins by [155] (GEO 
accession number GSE13135). The mRNA levels bound to each RBP were measured 
using the C-terminal tandem affinity purification (TAP)-tagged proteins and were affinity 
  
75 
purified from whole cells grown in YPD. The data includes 2 to 6 replicated for each 
factor total among cDNA and oligonucleotide microarray thus having total of 132 IP 
experiments. 
 For aQTL analysis, we used the genome-wide mRNA expression data (GEO 
accession GSE9376) using a similar approach done by [90]. 108 haploid segregants 
mRNA expression levels from a genetic cross between two parental strains BY and RM 
were measured. The log2 ratios are between segregants and the BY mRNA differential 
levels. The pre-processing on the expression data is the same as done by [90]. As for 
genotype data, we used [19] data for the same segregants for total of 2956 markers.  
4.2.3.2 PSAM search 
We used the normalized log2 ratios between the mRNA level bound to a protein and the 
control from the RBP binding data set. To correct for the effect of outliers, we applied a 
rank-quantile transformation. For each IP experiment, we first ranked the normalized log2 
values among all genes and then assign the quantile values to the ranked values. This 
way, we diminish the values points located in the long tails of the distribution.  
 We used the MatrixREDUCE program from the REDUCE Suite 
(http://bussemakerlab.org/software/REDUCE) to perform a genomewide fit of a position-
specific affinity matrix (PSAM) to the rank-quantiled normalized log2 ratios of IP 
experiments. For every RBP, we searched for binding motifs on the whole mRNAs, 5ʹ′ 
UTRs, ORFs and 3ʹ′ UTRs sequences separately. We obtained the Saccharomyces 
cerevisiae UTR sequences from a study using RNA-seq method to obtain the 
transcriptional landscape of the yeast genome by [156]. ORF sequences were downloaded 
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from Saccharomyces Genome Database (SGD; http://www.yeastgenome.org). The final 
set of PSAMs was obtained from the PSAMs that pass the test for specificity to their own 
IP experiment among all the experiment and If the affinity of a specific PSAM on UTRs 
and/or ORFs had the highest correlation to at least one of the relevant IP experiments 
among the 132 experiments, that RBP-mRNA region combination would pass our test.  
4.2.3.3 Inferring segregant-specific RBP activities 
From our RBP PSAM search we obtained 25 independent RBP-region factors. As for the 
previous work by [90], we used the total sequence affinity of the PSAMs as a predictor 
for mRNA differential expression levels in the low protein concentration region 
established by [78]. Thus we considered the RBP sequence occupancy to be proportional 
to the total affinity of a desired PSAM for a sliding window along the whole mRNA, 
UTRs or ORF sequences. We performed a genome-wide multivariate regression between 
the 25 factors we had obtained from the RBP PSAM search and specificity test step and 
every segregant mRNA expression log2-ratios. For the case of protein level, we 
performed the regression between the affinities and every segregant protein levels. 
4.2.3.4 aQTL mapping 
Significant aQTL region were discovered by splitting the multivariate regression 
coefficient between BY and RM at every marker and testing for the significance of the 
difference between the distributions of the two groups of coefficients using composite 
interval mapping (CIM) method for maximum resolution. Thus LOD score was 
calculated to check for the effect of each locus on the activity of the RBPs. We performed 
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200 independent random permutations on the expression data for each gene among the 
segregants (preserving the genotype data) to get LOD score threshold at 1% FDR level. 
We obtained this threshold for each factor separately. 
 To ensure that the detected aQTL regions for the RBPs are modulated by trans-
acting factors and also not dominated by a single gene eQTL, once we obtained the 
significant regions we re-did the analysis after eliminating 3 groups of genes: gene that 
encode the RBPs, genes fully or partly located within about 10 kb up- and down-stream 
of obtained aQTL regions and genes with significant eQTL peak located 20 kbp window 
around detected aQTL marker and have affinity higher than 50% of max affinity score for 
the RBP under study. To find the last group, we did our QTL analysis using the 
expression of each gene as trait and calculated LOD score for every marker using CIM 
method. We combined these 3 groups of genes and eliminated them for each RBP 
separately, thus not affecting the activity calculation of each factor by eliminating 
unrelated genes for it. Same procedure was performed for calculating aQTL profile using 




Chapter 5                                                     
Identifying regulatory mechanisms underlying 
tumorigenesis 
This chapter has been adapted from a manuscript co-authored by Eunjee Lee, Jeroen de 
Ridder, Lodewyk Wessels and Harmen J. Bussemaker. It is in preparation to be submitted 
for publication in the near future.  
5.1 Abstract  
Retroviral insertional mutagenesis (RIM) is a powerful tool for identifying putative 
cancer genes in mice. To uncover the regulatory mechanisms by which common insertion 
loci affect downstream processes, we supplemented genotyping data with genomewide 
mRNA expression profiling data for 97 tumors induced by RIM [68]. We developed 
LESA: locus expression signature analysis, an algorithm to construct and interpret the 
differential gene expression signature associated with each common insertion locus. 
Comparing locus expression signatures to promoter affinity profiles allowed us to build a 
detailed map of transcription factors whose protein-level regulatory activity is modulated 
by a particular locus. Surprisingly, we found that the transcriptional response to insertion 
at the MYC locus is dominated by Myc binding events downstream of transcription start 
sites. Our analysis also revealed the induction of a large multi-gene chromosomal domain 
in response to insertions near the PVT1 gene. Taken together, our results demonstrate the 
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potential of a locus-specific signature approach for identifying mammalian regulatory 
mechanisms in a cancer context. 
5.2 Introduction 
Cancer arises as a result of the accumulation of genetic and epigenetic changes, which 
each deregulate a specific aspect of normal cell function. High-throughput technologies 
for mapping genetic and chromosomal aberrations have revealed complex changes in 
genomes of individual tumors [40-43]. Mouse retroviral insertional mutagenesis has been 
used as an efficient tool for identification of causal mutations in cancer [44, 45]. Such 
oncogenic mutations may either cause alteration of a gene product or influence the 
expression levels of one or more genes surrounding the insertion.  
 A high-throughput screen in mice for mutations collaborating with either p19ARF 
or p53 deficiency was performed yielding over 10,000 independent insertion sites for 
more than 500 tumors [61]. To date, more than 10,000 genomic regions where retroviral 
insertions have been found in close proximity in multiple tumors (referred as Common 
Insertion Sites or CIS) have been identified in previous studies (Retroviral Tagged 
Cancer Gene Database (RTCGD), http://variation.osu.edu/rtcgd [62]). However, 
insertional mutagenesis screens have an important limitation. It is not straightforward to 
determine which genetic lesion near the CIS is playing a causal role in oncogenesis. 
Methods to predict target genes affected by insertions based on information about 
insertions such as orientation have been developed [68]. However, these are based on 
gene annotation and do not use or provide functional evidence, i.e. whether the mRNA 
expression level of the predicted target genes is affected by insertions. Analyzing the 
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mRNA expression level of the genes near the insertion site is often not sufficient, as the 
lesion may exert its effect only at the post-translational level. Furthermore, retroviral 
insertional mutagenesis screens alone rarely elucidate the regulatory mechanisms that 
drive tumorigenesis. These limitations highlight the need for new approaches that can 
integrate the genetic data with functional genomics data and other information in order to 
identify causal genes and regulatory mechanisms underlying cancer. 
 For these reasons we carried out genomewide expression profiling in a set of 
tumors induced by retroviral insertional mutagenesis. We furthermore describe a novel 
approach that first defines and then analyzes the genomewide mRNA expression 
response that is induced by the putative causal gene near the insertion locus. We refer to 
our method as Locus Expression Signature Analysis (LESA). We analyzed genome-wide 
expression profiles for a panel of splenic tumors induced by retroviral insertional 
mutagenesis [68]. To identify regulatory mechanisms underlying tumorigenesis, we 
hypothesized that gene expression is affected by insertional mutations through one of two 
regulatory mechanisms: (i) regulation by sequence specific transcription factors (TFs) or 
(ii) changes in chromosomal domain organization leading to changes in gene expression. 
We construct a map that connects each insertion locus with the TFs whose regulatory 
activity is affected by it. This map contains both know and new associations. LESA also 
provides an opportunity to analyze transcriptional regulation mechanisms in great detail. 
In particular, we show that the MYC expression signature is mainly driven by promoter-
proximal downstream binding of the c-Myc transcription factor to the transcription start 
site (TSS) of its target genes. LESA also identified a large chromosomal domain on 
  
81 
chromosome 15 in which most genes are induced by viral insertions at the PVT1 locus. 
Together, our results demonstrate the ability of LESA to identify candidate regulatory 
mechanisms in cancer. 
5.3 Results  
5.3.1 Identifying common insertion sites  
Many insertion regions are tagged in multiple independent tumors. To identify common 
insertion sites (CISs), i.e., regions in the genome that are significantly more frequently 
mutated by insertions than would be expected by chance, we used a statistical framework 
based on Gaussian kernel convolution (GKC), which estimates a smoothed density 
distribution of inserts over the entire genome [67] Next, we applied rule-based mapping 
(RBM), which maps individual insertions to target genes based on orientation-dependent 
windows and information regarding repetitive occurrence of insertions at a given locus 
across tumors [68]. We identified 87 insertion sites, and assigned a potential modulator 
gene that generates the tumors in collaboration with the loss of p53 and p19ARF. For 
further analysis, we selected 13 insertion loci that occur in more than 10 tumors. The loci 
include known oncogenes such as NOTCH1, c-MYC and n-MYC.   
5.3.2 Locus Expression Signature Analysis (LESA) 
Our hypothesis is that an insertional mutation perturbs the function or expression level of 
the proximal causal gene contributing tumorigenesis in collaboration with loss of p53 or 
p19ARF, and the perturbed causal gene in turn influences the function or expression level 
of downstream target genes in the signaling pathway (Figure 5.1A). Therefore, the 
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contribution to tumorigenesis by a causal mutation might have a characteristic gene 
expression signature associated with it. Based on this assumption, we inferred locus 
expression signatures (LES) representing the average difference in mRNA expression 




Figure 5.1: The overview of LESA. (A) The proviral insertion in to host genome perturbs 
the function or expression level of the proximal causal gene contributing tumorigenesis in 
collaboration with loss of p53 or p19ARF, and the perturbed causal gene in turn influences 
the function or expression level of downstream target genes in the signaling pathway (B) 
The contribution to tumorigenesis by a causal mutation might have a characteristic gene 
expression signature associated with it. Based on this assumption, we inferred locus 
expression signatures (LES) representing the average difference in mRNA expression 
between the tumors carrying insertions at a particular locus and all other tumors using 
common insertion sites data and gene expression data for each tumor. These LES are 
used for further analyses including finding significant GO category, differential TF 
activities, chromosomal domain and drug responses to identify regulatory mechanisms 
underlying tumors.  
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In a previous analysis of the insertion data per se [61], insertion loci and genetic 
background (e.g.p19ARF-/-, p53-/-, and wild-type) were found to co-occur across tumors, 
which is an indication for collaboration between these lesions in driving tumorigenesis. 
To deal with this dependency, we used a multivariate linear model to explain the 
variation in mRNA expression level for each gene in terms of the pattern of insertions in 
a given tumor (Figure 5.1B). The coefficients from this fit, aggregated across all genes, 
constitute our collection of locus expression signatures. For each insertion locus, we 
compared the variance of the signature value across all genes with its null distribution 
(see Methods). We found that for most loci the information contained in their signature is 
highly statistically significant (Figure 5.2B). This encouraged us to dissect the regulatory 
mechanisms that give rise to these signatures.  
5.3.3 Regulation of individual genes as identified by LESA.  
The absolute value of the locus expression signature is highest for genes whose 
expression level is most strongly affected by the associated genetic mutation. As 
expected for the signatures we inferred for the contribution of the p53-/- and p19ARF-/- 
deletion backgrounds, respectively, Trp53 had the most negative value in the p53 
signature, while the p19ARF isoform Cdkn2a showed one of the most negative p19ARF 
signature values (Table 5.1). We also found an association between the loss of p53 and 
the increase of Cdkn2a expression, suggesting a feedback mechanism compensating for 
the loss of p53. Among the remaining signatures, i.e., those associated with common 
insertion loci, we detected strong cis-association for NOTCH1, RASGRP1, GFI1, and 
RRAS2, with retroviral insertions either increasing or decreasing the mRNA expression 
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level of the gene designated as their primary target (Table 5.1). To analyze the extent to 
which an insertion could have a wider local effect, we inspected the expression signature 
values near the insertion locus. The expression of multiple genes proximal to CCND3 and 
RUNX1 was highly induced by retroviral insertion (Figure 5.2A). In other cases, 
insertions may affect genes at the protein level rather with no apparent change at the 
mRNA level (as exemplified by the MYC expression signature in Figure 5.2A), resulting 
in the change in the transcription level of functionally related or known direct target 
genes. Examples in Table 1 include the CCND3 locus influencing the mRNA of its know 
target Ccnd2 [159], and the MYC locus that of Ccnd2 [160]. We found that the gene 
Adam19 has a high NOTCH1 signature value, suggesting a positive feedback loop: 
Adam19 is a metalloprotease known to activate Notch1 by cleaving it [161].    
p19 p53 Notch1 Myc Med20/Ccnd3 
Slpi 0.77 Cdkn2a 1.66 Gm12253 2.05 Myl1 0.94 Emb 0.66 
RP23-395H4.4 0.62 Cdkn2a 1.45 Notch1 1.92 Gimap7 0.64 Lysmd2 0.51 
NM_027222 0.61 Butr1 1.27 Dtx1 1.86 Grb7 0.57 Ly6k 0.50 
Reg1 0.58 Ifi27l2a 1.03 Aldh1b1 1.65 Chst2 0.56 Itgb7 0.49 
Try10 0.58 Isg15 1.03 NR_002860 1.45 Tns4 0.53 Gimap7 0.48 
Amy2 0.57 Sparc 0.90 Adam19 1.42 Ccnd2 0.52 Il18r1 0.47 
Vpreb3 0.56 Vpreb3 0.82 Spsb4 1.35 Cd160 0.51 Thy1 0.45 
Pnlip 0.56 Usp18 0.77 Rag1 1.35 Bmp7 0.47 Kcnf1 0.44 
Il4i1 0.55 Retnlg 0.65 Cd163l1 1.28 Rapsn 0.46 Gimap3 0.44 












Treml1 -0.23 NM_175332 -0.55 S100a10 -1.09 Prg2 -0.43 NM_027222 -0.46 
Cdr2 -0.23 Xist -0.55 Try10 -1.11 Rras2 -0.43 H2-T22 -0.47 
Cdkn2a -0.24 Lck -0.56 Prss2 -1.11 Ddc -0.46 Ccnd2 -0.48 
Serpine2 -0.24 Sh2d2a -0.58 Myl1 -1.17 S100a9 -0.46 Irf4 -0.49 
Ednra -0.25 Hdc -0.62 Amy2 -1.18 Pp11r -0.47 Plac8 -0.49 
Ddc -0.25 Thy1 -0.64 Clps -1.20 Gpc1 -0.50 Adam19 -0.50 
Ppbp -0.28 Cd3d -0.68 Zg16 -1.22 Cd163l1 -0.62 Notch1 -0.54 
Mpp4 -0.31 NM_009831 -0.69 Pnlip -1.27 Ly6d -0.64 Gm12253 -0.57 
Rsad2 -0.36 Cd3g -0.71 Pnliprp1 -1.46 Ccnd1 -0.68 Myl4 -0.57 
Gfi1 -0.39 Trp53 -1.77 RP23-395H4.4 -1.50 Satb1 -0.80 Myl1 -0.61 




Figure 5.2: Single-gene expression changes identified by LESA. (A) Box plot of locus-
expression signatures for each genotype (blue) and each insertion locus (black). Red spot 
represents the LES value of the near target gene. (B) Sum of squares of t-value 
corresponding to each LES (blue) and permuted values (pink) (C) LES values for genes 




Figure 5.3: Functional annotation using GO category. (A) Heatmap of significant GO 
categories for each LES at FDR 1%. (B) CDF plot of p19 and p53 LES for genes in M 
phase mitotic cell cycle  
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5.3.4 Expression signatures can elucidate the biological functions affected by 
insertions at specific loci. 
To explore the functional significance of the locus expression signatures, we used gene 
ontology (GO) terms to identify the biological process, molecular function, and cellular 
component categories enriched in each locus expression signature. We compared the 
distribution of the locus expression signature values in each particular GO category with 
that of the remaining genes using the Wilcoxon-Mann-Whitney (WMW) test. Since the 
GO categories are hierarchically organized, with overlapping gene sets that are mutually 
redundant, we used a forward selection scheme [149] to select a non-redundant set of 
significantly associated GO categories.  
 The resulting functional map provides several useful insights (Figure 3A). First, 
the GO categories associated with the p53-/- effect on expression are a subset of those 
associated with the p19ARF-/- background. For example, the “DNA repair” genes are 
suppressed in tumors lacking either p19ARF or p53, consistent with the known role of 
these genes as activators of DNA repair [162]. By contrast, the “M phase of mitotic cell 
cycle” genes are enriched only in the p19ARF expression signature (Figure 5.3B). This 
agrees with the fact that while p19ARF acts upstream of p53 by enhancing p53 activity 
[163], it may also suppress tumorigenesis independently of p53 [164, 165].  
 “Lysosome” genes are significantly associated with the p19ARF, MYCN, 
AC153556, and MED20/CCND3 signatures. The lysosome controls cell death and 
lysosomal alterations are common in cancer cells [166]. The mechanism mediating the 
effect of these insertions on the expression level of lysosomal genes is not clear. In 
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addition, we detected association with “mitochondrion” genes for several loci (p19ARF, 
NOTCH1, MYB, MYCN, and MYC). Interestingly, p19ARF and Myc are both known to 
regulate apoptosis via the release of cytochrome c from mitochondria [167, 168]. Several 
genes related to mitochondria-dependent apoptosis, including Hspd1 [169], Bnip3l[170], 
and cytochrome c oxidase genes Cox7a2 and Cox6c have among the lowest MYB 
expression signature values among genes within this category, suggesting an unknown 
role for Myb as a mitochondria-dependent apoptosis regulator. Furthermore, we found 
locus specific GO categories such as “T cell differentiation” for RASGRP1, consistent 
with the role of Rasgrp1 in T cell signaling [171], and “microtubule-based process” for 
RRAS2, supporting its role in the regulation of cytoskeleton and its participation in 
related function such as adhesion, migration, and invasion [172-174].  
 Our functional analysis revealed that, by and large, the insertion loci fall into two 
major groups, with opposite characteristics and opposite effects on expression across 
multiple pathways: MYCN-like (e.g., MYCN, RRAS2 and MED20/CCND3) and p19ARF-
like (e.g., p19ARF, p53 and GFI1). This observation implies that insertions either help or 
oppose each other in enhancing or abrogating tumorigenesis. The downstream 
consequences of loss of the tumor suppressor gene p53 or p19ARF are worsened by 
insertions near loci such as MYCN, RRAS2 and MED20/CCND3, but mitigated by 
insertion near GFI1. Indeed, we found a strong negative correlation between insertion 
near MYCN and mRNA expression of the MYC gene (t-value=19.94, p-value=8.9×10-
24), whose enhanced protein expression contributes to almost every aspect of tumor cell 
biology [175].   
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Using the functional map in Figure 5.3, we can predict whether the effect of a 
particular insertion effect is tumor-suppressive or oncogenic. This is especially useful for 
loci without any apparent cis-association at the mRNA level. For example, it is unclear 
whether insertion near MYB, RUNX1, and MED20/CCND3 up-regulates or down-
regulates the associated proximal gene. We found that the RUNX1 and MED20/CCND3 
signatures were similar to that of MYCN. This confirms that insertion near RUNX1 up-
regulates Runx1 mRNA expression (Figure 5.2A), which may act to abrogate the 
tumorigenesis; the reduced expression of Ccnd2 (Table 5.1) and induced expression of 
Ccnd3 (Figure 5.2A) predicted by LESA is consistent with a previous observation that 
over-expression of Ccnd3 results in reduced tumor development and strong reduction in 
Ccnd2 [159]. Conversely, the MYB signature is similar to that of p19ARF, suggesting a 
role in tumorigenesis. Myb protein activity, while subtle at the mRNA level (Figure 
5.2A), may be enhanced by the retroviral insertion. Indeed, MYB has been found to be 
oncogenically altered in human leukemia [176]. 
5.3.5 Detecting changes in protein-level TF activity associated with mutations. 
Having surveyed the gene function landscape associated with each insertion locus based 
on its genomewide expression signature, we next wanted to identify the specific trans-
acting regulatory mechanisms underlying their influence on the formation of tumors. We 
previously demonstrated that when the binding specificity of a TF is known (in the form 
of a weight matrix), quantitative changes in its regulatory activity can be inferred by 
performing genome-wide linear regression of a single genomewide differential mRNA 
expression profile on the predicted total in vitro binding affinity of cis-regulatory regions 
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[115], the regression coefficients corresponding to changes in TF activity. Here, we used 
a compendium of position weight matrices (PWMs) for 130 vertebrate TFs from the 
JASPAR database [177], and 11 family-level PWMs for well-characterized structural TF 
families [178].  We converted each PWM to an approximate position specific affinity 
matrix (PSAM) by assuming base frequencies to be proportional to relative binding 
affinities at each position within the binding site [114].  
 
Figure 5.4: Effect of DNA base composition on LES. R2 from a linear regression model 
between each LES and the frequency of DNA base composition including each DNA 
composition and CpG composition. Red represents downstream and blue represents 
upstream from transcription start sites (TSS). The DNA base composition for each gene 
and each window is calculated based on 1kb window sequence from TSS, then used as 




Using a sequence window from 200kb upstream to 200kb downstream of 
transcription start site (TSS) as the potential cis-regulatory region, we assumed the 
contribution to the transcription rate by any particular binding site to be proportional both 
to its binding affinity and to a positional weight decaying exponentially with the distance 
from the transcriptional start site (TSS); the corresponding length scale parameter was 
inferred from the data (see Materials and Methods for details). We found a relatively 
strong correlation between the locus expression signature value for each gene and the 
percentage of A, C, G, and T in its regulatory region (Figure 5.4). To avoid confounding 
due to these low-complexity signals, we inferred TF activities from the residuals of a 
linear regression of the signature on base composition (see Materials and Methods).  
5.3.6 A map of cancer-related TFs specifically regulated by viral insertions.  
Despite the fact that using a weight matrix to represent the target specificity of a 
transcription factor has some limitations, especially when it comes to distinguishing 
between TFs with closely similar sequence specificity, our method allowed us to make a 
number of interesting observations. Controlling for multiple testing – using stringent p-
value thresholds of 1.0×10-6 and 7.9×10-10 for familial and individual TF-locus 
associations, respectively, corresponding to a false discovery rate of 0.1% – we identified 
a total of 22 TF-locus associations (Figure 5.5B). These include known relationships, 
such as that of insertions at the p19ARF and MYCN loci activating REL family members 
NFKB1, NF-κB, RELA, and REL (p-value=9.2×10-13 and 2.5×10-11, respectively), which 
are known to promote the oncogenic phenotype such as angiogenesis, proliferation and 
invasion/metagenesis [179]; Mycn is also known to suppress the mRNA expression level 
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of p50 subunit of NF-κB [180]. Our algorithm also detected that one or more members of 
the Trp family of transcription factors (which includes Myb) are responsible for the 
transcriptional response to insertion at the MYB locus. Furthermore, the activity of the 
basic helix-loop-helix zipper (bHLH-zip) family is significantly affected by the loss of 
p53 as well as viral insertion near the MYC, MYCN, or PVT1 locus (Figure 5.5B). Some 
TFs are modulated by multiple mutations, such as E2F1, which mediates the 
transcriptional response to both the p19ARF background and to insertion at the CCND3 
locus (p-value = 1.8×10-18 and 1.2×10-10, respectively), consistent with the previous 
observation that human ARF binds to E2F1 to inhibit its transcriptional activity [181]. 
Other TFs only respond to insertion at one of the loci in our panel, such as the factor 
Pou5f1 to the NOTCH1 locus. Furthermore, an association found between the Myc locus 
and the factor SP1 supports their known cooperative interaction to activate transcriptions 






Figure 5.5: TF-locus associations. (A) Detecting TF-locus associations (B) Overview of 
significant familial and individual TF-locus associations at FDR 0.1%. (C) TFs that is 





Figure 5.6: Spatial style of regulation (A) Heatmap of t-value from a linear model 
between TF affinity and LES (B) Optimal parameter selected for each upstream and 
downstream sequence, showing that both the distance (proximal vs. distal) and direction 
(upstream vs. downstream) of regulation differs greatly among between TFs (C) 
Examples of regulation model: proximal upstream as well as downstream regulation, 
downstream dependent regulation, and distal regulation.  
5.3.7 TFs differ dramatically in their spatial style of regulation.  
We have shown above that using prior information about the network of interactions 
between TFs and their target genes (in the form of cis-regulatory sequence and weight 
matrices) can reveal the contributions of each common insertion locus to the differential 
activity of specific TFs or TF families (Figure 5.6A). As part of this procedure we 
(exponentially) weighted the strength of individual binding sites surrounding the 
transcription start site (TSS) in such a way that those closer to the TSS contributed more 
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heavily. Two parameters corresponding to the distance over which the contribution 
decreased to half the maximum value, one for sites upstream of the TSS and one for 
downstream sites, were fit to the data (see details in Materials and Methods). We were 
interested in exploring the detailed information provided by these parameters about the 
range over which cis-regulatory logic acts, as there is ongoing controversy about the size 
and orientation of the window around the TSS that is optimal to use when looking for TF 
binding sites. 
 Surprisingly, both the distance (proximal vs. distal) and direction (upstream vs. 
downstream) of regulation differs greatly among between TFs, in a way that is largely, 
but not entirely, dependent on the identity of the locus driving the TF activity change 
(Figure 5.6B). For example, the p19ARF expression signature is best explained in terms of 
E2F1 binding sites when proximal occurrences upstream as well as downstream of the 
TSS are counted as functional (Figure 5.6C). By contrast, we uncover a striking 
asymmetry in the contribution from REL family binding sites, with only predicted 
binding sites upstream of the TSS (both proximal and distal) being useful for predicting 
the genomewide differences in expression due to the p19ARF background (Figure 5.6C).   
5.3.8 Myc as a regulator of transcriptional elongation.  
Of particular interest among our findings was that the association between predicted 
binding affinity for Myc and the expression response to insertions at the MYC locus is 
limited to the proximal, downstream cis-regulatory region, with only binding sites within 
~300 bp downstream of the TSS contributing, and not binding sites upstream, not even 
close to the TSS (Figure 5.6C). A plausible mechanistic explanation for this observation 
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is that Myc acts as a transcriptional elongation control factor. Indeed, it was recently 
found that Myc can bind to positive transcription elongation factor b (P-TEFb) and 
thereby stimulate elongation at specific genes in tumor cells [184]. Since there is no 
significant correlation between Myc mRNA expression level and the presence of an 
insertion at the MYC locus, insertions near MYC are likely to act post-transcriptionally, 
possibly through disruption of a protein domain mediating the interaction with P-TEFb. 
 According to our analysis, viral insertions near MYC change the protein-level of 
the Myc transcription factor, which in turns modulates genomewide mRNA expression 
level, but only via binding downstream of, and proximal to, the TSS. To validate our 
findings, we analyzed gene expression profiles obtained after Myc inactivation using 
doxycycline treatment [185]. Analyzing the genomewide profile of differential mRNA 
expression between Myc-inactivated and mock-treated cells in exactly the same way as 
the MYC locus expression signature (Figure 5.7A), we found significant differential 
activity both for bHLH factors at the family level and for the bHLH factor Myc at the 
single-TF level. Since again our analysis indicated that the response to Myc inactivation 
is caused by Myc binding sites downstream of the TSS (Figure 5.7B), we conclude that it 






Figure 5.7: Validation of regulation under MYC expression signature. (A) Scatter plot of 
–log(p-value) for each TF.  The significance levels of differential TF activities in 
response to MYC inactivation (x-axis) and in response to MYC insertion (y-axis) are 
shown. (B) R2 plot from a linear model between each window affinity of Myc and the 
differential gene expressions in response to Myc inactivation, showing detected 
differential gene expressions in response to Myc inactivation are also mainly determined 




5.3.9 Pvt1 regulates a multi-gene chromosomal domain on chromosome 15.  
So far, we have analyzed TF-mediated changes in mRNA expression in a manner that is 
oblivious to how genes are distributed over the chromosomes. However, regional 
regulation of multiple neighboring genes through locus control regions has been 
documented [186, 187], and the rich array of locus-locus interactions observed in a 
typical mammalian cell [188] suggests that local modulation subnuclear organization 
might provide a mechanisms for coordinately controlling adjacent genes. We reasoned 
that are our locus expression signatures provide a natural opportunity to investigate this. 
Therefore, we adopted a “domainogram” approach from a previous study [189] to detect 
chromosomal domains within which the distribution of a given locus expression signature 
was non-random (Figure 5.8). For each window of n consecutive genes, we tested 
whether the distribution of signature values differed from the distribution of genes in the 
rest of the whole genome using a Wilcoxon-Mann-Whitney test. This allowed us to 
visualize the statistical significance of the local enrichment of signature values for all 





Figure 5.8: Detection of chromosomal domain organization. For each LES and each 
window of n consecutive genes, we tested whether the distribution of LES values differs 
from the distribution of genes in the whole genome using Wilcoxon-Mann-Whitney test, 
resulting in domainogram. It shows domainogram of PVT1 expression signature on 
chromosome 15. 
For each insertion locus, we generated domainograms across all chromosomes. 
Several insertion loci show domain behavior. For the PVT1 locus, this identified a region 
on chromosome 15 within which genes are collectively induced (Figure 5.8). 
Significantly, the PVT1 locus is also located on the chromosome 15, suggesting a locus-
control-region type of regulatory mechanism. We observed a significant bias in DNA 
base composition and CpG content on chromosome 15 (results are not shown). However, 
these low-complexity features were not found to be predictive of the PVT1 signature (p-
value > 0.1). Moreover, the PVT1 domain structure remained unchanged after we 
explicitly removed low-complexity signals (results are not shown). We conclude that the 
domain structure of the transcriptional response to viral insertion at PVT1 is not driven 
by low-complexity signals per se, and therefore may result from a local reorganization of 
the nucleus.  
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5.3.10 Relating drug response to locus expression signatures. 
There is a close analogy between how a viral insertion and a drug affect the cell state at 
various levels, including that of the transcriptome. In fact, our study could be viewed as 
an attempt to uncover the “mode-of-action" of viral insertion at a specific locus. To 
systematically search for drugs that might move the cell state in a direction opposite to 
the change in cell state caused by to a specific mutation, we analyzed data from the 
Connectivity Map, encompassing 7,000 genomewide expression responses to 1309 
different compounds [190]. We performed genome-wide linear regression between locus 
expression signatures and drug response profiles to identify drug-locus associations and 
predict the drug response of tumors with specific viral insertions (Figure 5.9).   
 We found a total of 281 significant drug-locus relationships at a false discovery 
rate of 1% (Figure 5.10A). A negative correlation between locus signature and drug 
response indicates that the drug might mitigate the effect of the insertion on 
tumorigenesis; a positive correlation indicates that the drug might exacerbate it. We 
found that 10 out of 15 loci were significantly associated with at least one significant 
candidate therapeutic drug. Interestingly, even though the overall patterns of drug 
association are similar for MYC and MYCN, these loci each had specific drug 
associations. The MYC signature has significant negative correlation with the response to 
PI3K inhibitors (i.e. wortmannin and LY-294002), while the response to histone 
deacetylases (i.e. valproic acid, trichostatin A, vorinostat, MS-275 and HC toxin) 
significantly antagonizes the MYCN signature (Figure 5.9A). Furthermore, our analysis 
predicts tumors with insertions at mmu-mir-106a to be responsive to topoisomerase 
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inhibitors (i.e. camptothecin, mitoxantrone, doxorubicin, daunorubicin and irinotecan), a 
well-known class of anti-cancer drugs. Taken together, our results suggest a strategy for 
predicting drug responsiveness from knowledge of the genotype of an individual tumor. 
We found most drug-locus associations to be independent of the cell-type in which the 
drug response was measured. Some notable exceptions to this trend are shown in Figure 
5.10B.  In HL60 cells, the response to genistein, which acts as a tyrosine kinase inhibitor 
and was identified as an angiogenesis inhibitor [191], shows a significant negative 
correlation with both the MYCN and MYC expression signatures. By contrast, the 
response to genistein in MCF7 cells correlates with the p19ARF-/- signature. 
 
Figure 5.9: Overview of our strategy for relating drug response to locus expression 
signatures. There is a close analogy between how a viral insertion and a drug affect the 
cell state at the level of transcriptome. We perform genome-wide linear regression 
between locus expression signatures and drug response profiles to identify drug-locus 
associations. The negative association represents cases where the effect of drugs is 





Figure 5.10: Heatmap of t-value showing drug-locus associations. (A) Significant Drug-
locus associations at FDR 1%. It is based on expression profiles averaged over the cell 
types in response to the same drug  (B) Cell type specific drug-locus associations 
  
103 
5.4 Discussion  
We have demonstrated here that using parallel genotyping data and genomewide mRNA 
expression data from mouse tumors generated by retroviral insertional mutagenesis 
greatly increases our ability to identify the regulatory mechanisms underlying 
tumorigenesis and the biological pathways affected by them. We use a mechanistic 
framework that allows us to attribute function to causal mechanisms in a way that would 
not be possible using retroviral insertional mutagenesis data alone. The information 
provided by the insertion loci and the gene expression data is highly complementary and 
synergistic. On the one hand, the insertional mutagenesis screen benefits from the 
selective pressure that is present during tumor growth. On the other hand, the genome-
wide expression profiles provide a high-dimensional downstream readout of the cell state.  
The locus expression signature analysis (LESA) approach presented in this paper 
allows us to exploit the genomewide transcriptional response to a change in the structure 
and/or expression level of the causal gene near the insertion locus, even if the latter is 
initially unknown. First, by integrating the locus expression signature with gene function 
annotation, we could map the influence of insertion at each common locus on various 
biological processes relevant to tumorigenesis. Second, systematic application of LESA 
uncovered a large number of connections between common insertion loci and their 
downstream gene regulatory mechanisms – some of which were known, and many of 
which were novel. 
In the first place, our results include many locus-TF associations, in which the 
regulatory activity of a particular TFs or TF family is modulated by viral insertion at a 
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particular locus. By construction, these associations are causal as well as functional. It 
should be noted that our method fully accounts for post-translational regulation of TF 
activity at the protein level. For example, we found Myc activity at the protein level to 
change in response insertions near the MYC locus, even though the mRNA expression 
level of the MYC gene does not change. Perhaps more surprisingly, in a different type of 
analysis, application of LESA helped reveal changes in chromosomal domain 
organization affected by viral insertions. For instance, we found that viral insertion near 
the PVT1 gene affects a large number of neighboring genes also located on chromosome 
15. This suggests viral insertion near PVT1 could locally change nuclear organization. 
This observation could be the consequence of genomic instability, which is a 
characteristic of almost all human cancers [192]. However, it is unlikely because our 
expression signature represents a consensus across many tumors. Furthermore, by 
relating our locus signatures directly to drug response profiles from the Connectivity 
Map, we were able to identify drugs that might specifically counteract the deregulatory 
effect of mutations at particular loci. A previous study [193] performed a large-scale 
integration of expression signatures of human disease from public data with drug 
response profiles from Connectivity map, and confirmed the usefulness of drug responses 
profiles to predict novel therapeutic indication.    
The mammalian genome is a complex landscape: some regions are very gene-
rich, whereas others are devoid of genes [194-196]. This variation in gene density is 
linked to large-scale variation in DNA base composition [195, 196]. GC content in turn is 
positively correlated with expression level [197]. To capture any such effects of low 
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sequence complexity, we considered DNA base composition as well as CpG content. We 
detected a high correlation between sequence composition and signature value for several 
loci including MYB, AC153556.2, and mmu-mir-106a~363. For most loci, the region 
downstream of the transcription start site (TSS) showed higher correlations than that 
upstream of the TSS. At the same time, loci such as MYCN, MYC and MED20/CCND3 
do not show any correlation with low-complexity sequence signals (Figure 5.4). The 
mechanism underlying these observations is not clear, and it would be interesting to 
further investigate them. To avoid confounding in our TF-centric analysis, we removed 
the low-complexity sequence effect in our analysis. 
Many of functional regulatory sites occur outside the proximal promoter for 
mammalian [198], and distal binding events up to 1Mb away from the TSS have been 
shown to contribute to p300 occupancy [199]. How the contribution of binding sites to 
transcriptional control depends on its proximity to the TSS has been previously quantified 
[200]. We considered 200kb upstream and downstream sequence from transcription start 
site (TSS) as the cis-regulatory region. However, to allow for variable relationships 
between binding positions and transcriptional control, we employed TF-specific length 
scale parameters and fit these by maximizing the correlation between the weighted TF 
affinity profiling and the locus expression signature. Surprisingly, we found that for 
various TFs including Myc, the transcriptional response to insertion at the locus is almost 
exclusively mediated by binding events downstream of the TSS, implying a role in 
transcriptional elongation or post-transcriptional regulation. Taken together, our analyses 
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have yielded a more comprehensive and detailed view of the oncogenic signaling 
networks and cis-regulatory mechanisms underlying tumorigenesis.   
5.5 Materials and Methods 
5.5.1 Retroviral Insertional mutation data 
Retroviral insertional mutagenesis screens have been performed previously [61]. Mice 
were infected with Murine leukemia virus (MuLV) at postnatal day 1 and monitored for 
tumor growth. MuLV infection accelerated lymphomagenesis in these mice. Mice 
developed tumors almost exclusively in spleen, thymus and lymph nodes. The gene 
expression levels of a subset of 97 retrovirally induced splenic lymphomas in p19ARF-/- 
(n=31), p53-/- (n=19) and wild-type (n=53) mice were measured and analyzed.   
5.5.2 Gene expression data  
Gene expression data were collected using Illumina MouseWG6-V2 beadchips, and 
normalized using variance-stabilizing transformation (VST) and robust spline 
normalization (RSN) [201]. Illumina probes with no corresponding RefSeq ID were 
discarded, leaving 45,281 measurements. Averaging over probes mapping to the same 
RefSeq ID resulted in expression values for 19,010 genes. 
5.5.3 Common insertion loci 
The effect of viral insertions on their nearby targets is dependent on the relative position 
and orientation of the target transcript as well as the orientation of the viral integration. 
To exploit this context information, we employed a rule-based mapping (RBM) 
procedure [68]. RBM assigns each insertion to one or more putative target transcripts 
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based on a set of rules that were distilled from literature. The unique list of transcripts 
that results from this procedure is used to generate a binary profile that, for each tumor, 
indicates if a transcript is a putative target or not. We observed that for proximal 
transcripts the same binary profile frequently results. These were therefore treated as a 
single profile. Only those transcript-insertion associations found in at least three tumors 
were considered in our analysis.   
5.5.4 Genome sequence and gene annotation  
We obtained mouse genome sequence from UCSC via the 
BSgenome.Mmusculus.UCSC.mm9 package in BioConductor [150]. We downloaded the 
corresponding genome annotation coordinates directly from genome.ucsc.edu (version 
mm9). 
5.5.5 Locus expression signature analysis (LESA)  
The variation in relative mRNA expression level across all tumors (represented as the 
log2-ratio relative to the mean across all tumors) was analyzed independently for each 
gene. To obtain locus expression signature values across all loci for a given gene, we 
performed analysis of variance (ANOVA) for the mRNA expression in terms of 
background genotype and insertion status at all loci considered, by fitting the following 
multivariate linear model: 𝐴!" = 𝛽!,!!"!"#𝐵!,!!"!"# + 𝛽!,!!"𝐵!,!!" + 𝛽!"𝐼!"!∈!  
Here,  Ag,t represents the relative mRNA expression level for tumor t and gene g. 𝐵!,!!"!"# and 𝐵!,!!" (taking values 0 or 1) indicate whether the genetic background of 
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tumor t is p19ARF-/- and p53-/-, respectively, while Imt indicates whether an insertion was 
present at locus m in tumor t. After this analysis had been completed for all genes, the 
expression signature for each background and for each viral insertion locus was 
constructed by combining the values of the pertinent regression coefficient β as a vector 
across all genes.   
5.5.6 Information content of locus expression signatures 
To assess how much information about downstream transcriptional regulation was 
contained in a given signature, without the need to specify a particular regulatory 
mechanism, we summed the squares of the t-values tgm corresponding to the regression 
coefficients βgm: 
𝜒!! = 𝑡!"!!  
To determine the statistical significance of the χ2-statistic, we constructed a null 
distribution by performing 100 independent random permutations of all tumors, in a way 
that preserved the correlation structure between insertion loci.  
5.5.7 Forward selection of GO categories 
Functional annotation of genes in terms of Gene Ontology (GO) categories was 
performed using a variation of the T-profiler algorithm [149], including an iterative 
procedure to select a non-redundant set of gene sets from those that have a significantly 
different expression distribution from the other genes. For each GO category, we applied 
the Wilcoxon-Mann-Whitney (WMW) test to detect differences in distribution between 
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the locus expression signature value of genes within the GO category and that of the 
other genes. At each step, we subtracted the mean signature value of the genes in the gene 
set with the lowest p-value from all genes in that gene set. The p-values were then 
recalculated and the procedure repeated until even the most significantly regulated gene 
group had a p-value > 10-5, which corresponds to a false discovery rate (FDR)  <0.1%. 
Statistical significance was determined by performing independent random permutation 
of the signature values for each gene. The FDR corresponding to a given p-value 
threshold was computed as the ratio of the number of GO categories with a p-value below 
threshold, averaged over 50 randomized data sets, and the number of GO categories with 
p-value below threshold. A 1% FDR based on the empirical permutation test corresponds 
to a WMW test p-value <10-4. 
5.5.8 Low-complexity sequence features  
To eliminate the potential confounding contribution from low-complexity sequence 
features to locus expression signatures (LES), we calculated the frequency of each base 
and the CpG dinucleotide across the transcribed region for each gene. Next, we computed 
the residuals from a multiple linear regression of each LES on these five frequencies 
(without an intercept). We used these in further TF-locus association analyses.  
5.5.9 Weight matrices 
TFs from the same structural family tend to bind to similar DNA target sequences [202]. 
Our analysis explicitly recognizes that it is often not possible to implicate a specific TF 
based on its binding specificity alone. The JASPAR database [203] contains models at 
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the level of structural families with the shared DNA binding structures[178]. We 
downloaded 11 PWMs representing a distinct TF family from the JASPAR FAM 
database as well as 130 PWMs that are supposed to represent individual TFs from 
JASPAR CORE database. 
5.5.10 TF binding affinity   
We used the convert2psam utility from REDUCE Suite version 2.0 software package 
(bussemakerlab.org) to convert each PWM from JASPAR to a position-specific affinity 
matrix or PSAM [114]; pseudo-counts equal to one were added to the PWM at each 
position, and the resulting base counts were divided by that of the most frequent base at 
each position to get an estimate for the relative affinity associated with each point 
mutation away from the optimal binding sequence. The resulting PSAM collection was 
used to compute a weighted promoter affinity for each gene. All putative individual 
binding sites in the genomic region from 200kb upstream to 200kb downstream of the 
TSS of each gene with a predicted relative affinity of at least 0.1 were identified and 
scored using the AffinityProfile utility in the REDUCE Suite. To obtain a total weighted 
upstream affinity for a given value of the regulatory scale parameter λ, we summed the 
affinity of all upstream binding sites using a weight exp(-d/λ), where d is the (absolute) 
distance of a given binding site from the TSS. A total downstream affinity was computed 
in an analogous manner.    
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5.5.11 Mapping locus-to-TF network connectivity  
To treat the attribution of a regulatory role to TFs with similar sequence specificity in a 
conservative manner, we applied a two-step procedure. First, we performed multivariate 
linear regression of low-complexity-signal-corrected LES values (see above) on the 
weighted binding affinities for each TF family. Next, the residuals from this fit were 
regression on affinity profiles for individual TF. We computed p-values using ordinary 
linear regression. Statistical significance was determined by performing 1000 
independent random permutation of for each gene. A 0.1% false discovery rate (FDR) 
based on the empirical permutation test for family-level and individual PSAMs 
corresponded to a p-value <1.0×10-6 and <7.9×10-10, respectively. 
5.5.12 Validation of MYC result   
We downloaded gene expression profiles obtained by [185] for transgenic mice that 
conditionally express the human MYC cDNA in T-cell lymphocytes (GEO accession 
number GSE10200). In this transgenic mouse, doxycycline treatment suppresses MYC 
expression. The authors measured gene expression at different doxycycline 
concentrations, and found that a doxycycline threshold level of 0.05ng/ml was required to 
maintain the tumor phenotype. We only used the two most extreme doxycycline 
concentrations of 0ng/ml and 20ng/ml. To obtain an estimate for the differential 
expression level in response to inactivation of Myc, we subtracted the treatment/reference 
log2-ratio at 0ng/ml from that at 20ng/ml. These values served as the dependent variable 
in the regression on TF affinity profiles.   
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5.5.13 Identifying regulation at the level of multi-gene chromosomal domains 
To test whether the distribution of locus expression signature values across any given 
number of adjacent genes differed from that of genes in the whole genome, we adapted a 
procedure used by [189]. Within each chromosome, we first sorted genes by their TSS. 
For every possible set of n adjacent genes, we performed a WMW test. The resulting p-
values were visualized as triangular graph, with window position indicated on the 
horizontal and window size on the vertical axis. 
5.5.14 Mapping drug-locus associations 
Genomewide mRNA expression data for cultured human cells treated with bioactive 
small molecules were downloaded from the Connectivity Map website 
(www.broadinstitute.org/cmap/). This collection contains 7056 expression profiles for 
1309 distinct compounds. The experiments were carried out on two different Affymetrix 
GeneChip designs (HG-U133A and HT-HG_U133A), and in four different cell lines (the 
breast cancer epithelial cell line MCF7, the prostate cancer epithelial cell line PC3, 
nonepithelial leukemica cell line HL60, and nonepithelial melanoma cell line SKMEL5). 
We followed the preprocessing and normalization steps described in [190] to obtain the 
expression log2-ratio between drug treatment and control. To combine the human drug 
response expression data with our mouse-based locus expression signatures, we needed to 
map human Affymetrix probe IDs to mouse RefSeq IDs. For this, we used human-mouse 
orthology tables downloaded from UCSC (genome.ucsc.edu/). We averaged over the 
Affymetrix probes mapping to the same mouse RefSeq ID, resulting in 9757 genes shared 
between both data sets. 
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 To obtain robust results, we filtered out non-informative genes using two criteria. 
First, only mouse genes showing a high variance across tumors (upper 50 percentile) 
were retained. Second, we deleted human genes whose expression was detected in neither 
treatment nor control. Next, we calculated averages of gene expression levels across 
profiles for the same drug in different cell types, resulting in 1309 drug signatures. 
Multivariate linear regression of each of these on the locus expression signatures was 
performed. To determine the statistical significance of each putative drug-locus 
association, we performed 100 random permutations of drug signatures and repeated the 
analysis. A 1% false discovery rate (FDR) corresponded to a regression coefficients 
whose t-value has an absolute value >7. To explore the impact of physiological context 
on drug-locus associations, we calculated cell-type-specific drug responses by averaging 
only over replicate profiles for the same cell type, resulting 3587 cell-type-specific drug 




Chapter 6                                                    
Concluding Remarks  
In this dissertation, I have presented two approaches to dissect the mechanisms 
underlying genetic variants in gene expression through a TF-centric point of view. The 
following concluding remarks address future directions for this research and potential 
applications of our approaches.  
6.1 Hypotheses to be experimentally validated  
Both studies in this dissertation led to hypotheses that may be tested experimentally, and 
for which some supporting evidence has come to light.  
6.1.1 Genetic modulators of transcription factor activity  
In Section 3.3.6, we predicted that the region on chromosome 2 contains a genetic 
modulator of several transcription factors including Fkh1, Fkh2, Swi5, Ace2 and Stb1 
based on protein-protein interaction. The locus contains the CDC28 gene, which encodes 
a cyclin-dependent kinase. In particular, we predicted that the sign of the aQTL linkage to 
the CDC28 locus for Fhk2p is the opposite of that for Fkh1p (Figure 3.8A): whereas the 
transcriptional targets of Fkp1p are more highly expressed in segregants carrying the BY 
allele at the CDC28 locus, the opposite is true for the targets of Fkh2p (Figure 
3.8B). Even though no amino-acid change is detected by alignment of the BY and RM 
protein sequences for Cdc28p, alignment of BY and RM coding regions for CDC28 gene 
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reveals each point mutation in 3’UTR and 5’UTR. While the locus coincides with a 
previously identified eQTL hotspot and AMN1 in this region was experimentally 
validated to control transcriptional rates [32], CDC28 has not previously been identified 
as a trans-acting genetic modulator, and none of the TFs we identified except Ace2 has 
been previously implicated with the hotspot. Therefore, the effect of CDC28 
polymorphisms on TF activities could be tested by measurement of expression changes of 
allele replacement strains at CDC28, and one would expect the target genes of these TFs 
are differentially expressed in response to allele swap of CDC28. Additionally, we 
detected novel trans-acting polymorphisms in the TF-encoding gene STB5, RFX1, 
and HAP4 in Section 3.3.5.  To test this observation, one could measure the expression 
levels of genes in allele replacement strains at these TFs genes, and expect their target 
genes are affected by it.  
6.1.2 Regulatory mechanisms underlying tumorigenesis    
In Section 5.3, we predicted several regulatory mechanisms underlying tumorigenesis. 
One of our findings is the existence of a large region on chromosome 15 in which most 
genes are induced by insertions near PVT1 (see Section 5.3.9). Indeed, PVT1 is located 
on chromosome 15, suggesting a regional effect of viral insertion on the expression of 
multiple genes. Interestingly, PVT1 whose full name is plasmacytoma variant 
translocation 1 is the site of reciprocal translocations to immunoglobulin loci, resulting in 
'variant' translocations, T(2:8) or T(8:22) in Burkitt’s lymphoma [204]. In most murine 
plasmacytomas, t(15:12) translocations, analogous to the T(8:14) translocations in 
Burkitt's lymphoma, t(6:15) translocations are observed [205, 206]. These previous 
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studies suggest one possible mechanism by which a retroviral insertion near PVT1 locus 
can induce translocation and changes chromosomal territories, resulting in induced 
expression levels for the large number of genes on chromosome 15. The experiment 
visualizing locations around PVT1 locus by fluorescence in situ hybridization (FISH) for 
the tumors with PVT1 insertion could be performed, and compared to other tumors to see 
whether the chromosomal domains are changed for these tumors. Furthermore, we 
detected the chromosomal domain on chromosome 15 in which many genes are repressed 
in response to PIM1 insertion (Figure 6.1). Interestingly, genome-wide translocation 
sequencing reveals that double-strand breaks (DSBs) at c-myc oncogene on chromosome 
15 were preferentially targeted some chromosomal regions, including PIM1 on 
chromosome 17 [207]. Chromatin interaction profiling using Hi-C experiment [188] or 
FISH experiment could be performed to validate this observation.     
 
Figure 6.1: Domainogram of each chromosome for PIM1 expression signature. 
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 In Section 5.3.11, we investigated the relationship between drug responses and 
locus-specific expression signatures, and detected several insertional mutation-specific 
drug responses. Interestingly, even though the overall patterns of drug association are 
similar for MYC and MYCN, these loci each had specific drug associations. The MYC 
signature has significant negative correlation with the response to PI3K inhibitors (i.e. 
wortmannin and LY-294002), while the response to histone deacetylases (i.e. valproic 
acid, trichostatin A and HC toxin) significantly antagonizes the MYCN signature. 
Furthermore, our analysis predicts tumors with insertions at mmu-mir-106a to be 
responsive to topoisomerase inhibitors (i.e. camptothecin, mitoxantrone, doxorubicin, 
daunorubicin and irinotecan), a well-known class of anti-cancer drugs. The response of 
tumor carrying these insertions to each drug could be observed to validate our 
observation.  
6.2 Applying to other data sets 
6.2.1 Application of aQTL approach 
Our aQTL approach in Chapter 3 is generally applicable whenever a matrix of connection 
strength between regulators and targets, independent of the phenotype matrix, is available 
as prior information. In collaboration with other Bussemaker lab members, I have 
extended this approach to other biological contexts, including the promiscuous binding of 
TFs to high-occupancy target (HOT) regions and post-transcriptional regulatory networks 
(see Chapter 4). Furthermore, an obvious extension of the analysis in Chapter 3 would be 
to apply the approach to other organisms’ eQTL datasets, for example, human. The 270 
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individuals in the four HapMap populations were previously genotyped [208] from 
International HapMap project. The gene expression measurements from genes spanning 
the genome of EBV-transformed lymphoblastoid cell lines were obtained from the same 
individuals used in the phase 1 and phase II of the project [31]. Additionally, RNA-seq 
data that enable the analysis of transcript variation at unprecedented resolution from 
unrelated Nigerian individuals are available [209]. Furthermore, recent high-resolution, 
and high-throughput protein binding microarray (PBM) [210, 211] array data for defining 
the in vitro sequence specificity of a substantial subset of mammalian transcription 
factors could be used. Application of our aQTL approach would provide insights about 
transcriptional regulation of human.  
6.2.2 Application of LESA  
Recently, large-scale projects to map chromosomal aberrations, mutations and gene 
expression of cancer were launched by several groups. Genomic data has been collected 
for thousands of tumors at high-resolution using array comparative genomic 
hybridization (aCGH) [40], high density single nucleotide polymorphism (SNP) 
microarrays [41], and massively parallel sequencing [43]. Measurements of gene 
expression levels in parallel with these genomic data could be used to identify drivers of 
tumorigenesis and connected them to many of their targets and biological functions by 
applying our analysis. The genomic data could be treated in a way analogous to what we 
did for common insertion sites data in our analysis. Then, we would calculate expression 
signatures modulated by each genomic mutation in cancer. The resulting expression 
signatures could be used for further analyses such as GO analysis, identifying differential 
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TF activities and chromosomal domains. This application would facilitate identification 
of regulatory mechanisms underlying tumorigenesis.   
6.3 Integrating other layers of regulation  
The human genome is a store of information. The three billion bases encode, either 
directly or indirectly, the instructions for synthesizing all the molecules that form each 
human cell, tissue and organ. The genomic elements within the DNA sequence 
orchestrate the development and function of a human through multiple layers of 
regulations, including chromatin state [1], transcriptional rate [2], splicing [3], mRNA 
localization [4], mRNA stability [5], translational rate [6], and protein stability [7]. The 
Encyclopedia of DNA Elements (ENCODE) Project [212, 213] aims to provide a more 
biologically informative representation of the human genome by using high-throughput 
methods, including data about the degree of DNA methylation and chemical 
modifications to histones that can influence the rate of transcription. ENCODE also 
examines long-range chromatin interactions, such as looping, that alter the relative 
proximities of different chromosomal regions in three dimensions and also affect 
transcription. An obvious extension of the analysis described in Chapter 3 and Chapter 5 
would be the modification of algorithms to consider the additional layer of regulation 
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